{"id":43143,"date":"2015-09-17T11:25:58","date_gmt":"2015-09-17T16:25:58","guid":{"rendered":"https:\/\/content.findlaw-admin.com\/ability-legal\/contracts\/uncategorized\/agreement-and-plan-of-merger-ventritex-inc-and-st-jude.html"},"modified":"2015-09-17T11:25:58","modified_gmt":"2015-09-17T16:25:58","slug":"agreement-and-plan-of-merger-ventritex-inc-and-st-jude","status":"publish","type":"corporate_contracts","link":"https:\/\/corporate.findlaw.com\/contracts\/planning\/agreement-and-plan-of-merger-ventritex-inc-and-st-jude.html","title":{"rendered":"Agreement and Plan of Merger &#8211; Ventritex Inc. and St. Jude Medical Inc."},"content":{"rendered":"<pre>                          AGREEMENT AND PLAN OF MERGER\n\n                                      AMONG\n\n                                 VENTRITEX, INC.\n                             ST. JUDE MEDICAL, INC.\n                                       AND\n                                PACESETTER, INC.\n\n\n<\/pre>\n<table>\n<caption>\n                                TABLE OF CONTENTS<\/p>\n<p><s>                                                                                     <c><br \/>\nARTICLE 1<\/p>\n<p>THE MERGER&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..  1<br \/>\n         SECTION 1.2.   Effective Time&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.  1<br \/>\n         SECTION 1.3.   Closing of the Merger&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;  1<br \/>\n         SECTION 1.4.   Effects of the Merger&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;  1<br \/>\n         SECTION 1.5.   Certificate of Incorporation and Bylaws&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;  2<br \/>\n         SECTION 1.6.   Directors&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;  2<br \/>\n         SECTION 1.7.   Officers&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.  2<br \/>\n         SECTION 1.8.   Conversion of Shares&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.  2<br \/>\n         SECTION 1.9.   Exchange of Certificates&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;  2<br \/>\n         SECTION 1.10.  Stock Options&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..  4<\/p>\n<p>ARTICLE 2<\/p>\n<p>REPRESENTATIONS AND WARRANTIES OF THE COMPANY&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;  5<br \/>\n         SECTION 2.1.   Organization and Qualification; Subsidiaries&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.  5<br \/>\n         SECTION 2.2.   Capitalization of the Company and its Subsidiaries&#8230;&#8230;&#8230;&#8230;.  6<br \/>\n         SECTION 2.3.   Authority Relative to this Agreement&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;  6<br \/>\n         SECTION 2.4.   SEC Reports; Financial Statements&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;  7<br \/>\n         SECTION 2.5.   Information Supplied&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.  7<br \/>\n         SECTION 2.6.   Consents and Approvals; No Violations&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..  8<br \/>\n         SECTION 2.7.   No Default&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..  8<br \/>\n         SECTION 2.8.   No Undisclosed Liabilities; Absence of Changes&#8230;&#8230;&#8230;&#8230;&#8230;..  8<br \/>\n         SECTION 2.9.   Litigation&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..  9<br \/>\n         SECTION 2.10.  Compliance with Applicable Law&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;  9<br \/>\n         SECTION 2.11.  Employee Plans&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.  9<br \/>\n         SECTION 2.12.  Environmental Laws and Regulations&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 10<br \/>\n         SECTION 2.13.  Tax Matters&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 11<br \/>\n         SECTION 2.14.  Intangible Property&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 12<br \/>\n         SECTION 2.15.  Opinion of Financial Advisor&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 12<br \/>\n         SECTION 2.16.  Brokers&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 12<br \/>\n         SECTION 2.17.  Accounting Matters&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 13<br \/>\n         SECTION 2.18.  Material Contracts&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 13<br \/>\n         SECTION 2.19.  Products&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 13<br \/>\n         SECTION 2.20.  Amendment to Rights Agreement&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 14<\/p>\n<p>ARTICLE 3<\/p>\n<p>REPRESENTATIONS AND WARRANTIES<br \/>\nOF PARENT AND ACQUISITION&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 14<br \/>\n         SECTION 3.1.   Organization&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 14<br \/>\n         SECTION 3.2.   Capitalization of Parent and its Subsidiaries&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 15<br \/>\n         SECTION 3.3.   Authority Relative to this Agreement&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 15<br \/>\n         SECTION 3.4.   SEC Reports; Financial Statements&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 15<br \/>\n         SECTION 3.5.   Information Supplied&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 16<br \/>\n         SECTION 3.6.   Consents and Approvals; No Violations&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 16<br \/>\n         SECTION 3.7.   No Default&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 17<br \/>\n         SECTION 3.8.   No Undisclosed Liabilities; Absence of Changes&#8230;&#8230;&#8230;&#8230;&#8230;.. 17<br \/>\n         SECTION 3.9.   Litigation&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 17<br \/>\n         SECTION 3.10.  Compliance with Applicable Law&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 18<br \/>\n         SECTION 3.11.  Tax Matters&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 18<br \/>\n         SECTION 3.12.  Products&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 18<br \/>\n         SECTION 3.13.  Intangible Property&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 18<br \/>\n         SECTION 3.14.  Brokers&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 19<br \/>\n         SECTION 3.15.  Accounting Matters&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 19<br \/>\n         SECTION 3.16.  Telectronics Agreements&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 19<br \/>\n         SECTION 3.17.  Medtronic Agreement&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 19<\/p>\n<p>ARTICLE 4<\/p>\n<p>COVENANTS&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 19<br \/>\n         SECTION 4.1.   Conduct of Business of the Company and Parent&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 19<br \/>\n         SECTION 4.2.   Preparation of S-4 and the Proxy Statement&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 22<br \/>\n         SECTION 4.3.   No Solicitation&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 22<br \/>\n         SECTION 4.4.   Intentionally omitted&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 23<br \/>\n         SECTION 4.5.   Stockholder Meeting&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 23<br \/>\n         SECTION 4.6.   Access to Information&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 23<br \/>\n         SECTION 4.7.   Additional Agreements; Best Efforts&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 24<br \/>\n         SECTION 4.9.   Public Announcements&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 25<br \/>\n         SECTION 4.10.  Indemnification; Directors&#8217; and Officers&#8217; Insurance&#8230;&#8230;&#8230;&#8230; 25<br \/>\n         SECTION 4.11.  Notification of Certain Matters&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 26<br \/>\n         SECTION 4.12.  Pooling&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 26<br \/>\n         SECTION 4.13.  Tax-Free Reorganization Treatment&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 27<br \/>\n         SECTION 4.14.  Employee Matters&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 27<br \/>\n         SECTION 4.15.  Company Affiliates&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 27<br \/>\n         SECTION 4.16.  SEC Filings&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 27<br \/>\n         SECTION 4.17.  Guarantee of Performance&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 28<\/p>\n<p>ARTICLE 5<\/p>\n<p>CONDITIONS TO CONSUMMATION OF THE MERGER&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 28<br \/>\n         SECTION 5.1.   Conditions to Each Party&#8217;s Obligations to Effect the Merger&#8230;. 28<br \/>\n         SECTION 5.2.   Conditions to the Obligations of the Company&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 28<br \/>\n         SECTION 5.3.   Conditions to the Obligations of Parent and Acquisition&#8230;&#8230;.. 30<\/p>\n<p>ARTICLE 6<\/p>\n<p>TERMINATION; AMENDMENT; WAIVER&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 30<br \/>\n         SECTION 6.1.   Termination&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 30<br \/>\n         SECTION 6.2.   Effect of Termination&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 31<br \/>\n         SECTION 6.3.   Fees and Expenses&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 31<br \/>\n         SECTION 6.4.   Amendment&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 32<br \/>\n         SECTION 6.5.   Extension; Waiver&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 32<\/p>\n<p>ARTICLE 7<\/p>\n<p>MISCELLANEOUS&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 32<br \/>\n         SECTION 7.1.   Nonsurvival of Representations and Warranties&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 32<br \/>\n         SECTION 7.2.   Entire Agreement; Assignment&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 32<br \/>\n         SECTION 7.3.   Validity&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 33<br \/>\n         SECTION 7.4.   Notices&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 33<br \/>\n         SECTION 7.5.   Governing Law&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 33<br \/>\n         SECTION 7.6.   Descriptive Headings&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 33<br \/>\n         SECTION 7.7.   Parties in Interest&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 33<br \/>\n         SECTION 7.8.   Severability&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 34<br \/>\n         SECTION 7.9.   Specific Performance&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;. 34<br \/>\n         SECTION 7.10.  Subsidiaries&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 34<br \/>\n         SECTION 7.11.  Counterparts&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 34<br \/>\n<\/c><\/s><\/caption>\n<\/table>\n<p>                          AGREEMENT AND PLAN OF MERGER<\/p>\n<p>                  THIS AGREEMENT AND PLAN OF MERGER, dated as of October 23,<br \/>\n1996, is among VENTRITEX, INC.,a Delaware corporation (the &#8220;Company&#8221;), ST. JUDE<br \/>\nMEDICAL, INC., a Minnesota corporation (&#8220;Parent&#8221;), and PACESETTER, INC., a<br \/>\nDelaware corporation and a direct wholly-owned subsidiary of Parent<br \/>\n(&#8220;Acquisition&#8221;).<\/p>\n<p>                  WHEREAS, the Boards of Directors of the Company, Parent and<br \/>\nAcquisition each have, in light of and subject to the terms and conditions set<br \/>\nforth herein, (i) determined that the Merger (as defined in Section 1.1) is fair<br \/>\nto their respective stockholders and in the best interests of such stockholders<br \/>\nand (ii) approved the Merger in accordance with this Agreement;<\/p>\n<p>                  WHEREAS, for federal income tax purposes, it is intended that<br \/>\nthe Merger shall qualify as a reorganization within the meaning of Section<br \/>\n368(a) of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;); and<\/p>\n<p>                  WHEREAS, it is intended that the Merger shall be recorded for<br \/>\naccounting purposes as a &#8220;pooling-of-interests&#8221;.<\/p>\n<p>                  NOW, THEREFORE, in consideration of the premises and the<br \/>\nrepresentations, warranties, covenants and agreements herein contained, and<br \/>\nintending to be legally bound hereby, the Company, Parent and Acquisition hereby<br \/>\nagree as follows:<\/p>\n<p>                                    ARTICLE 1<\/p>\n<p>                                   THE MERGER<\/p>\n<p>                  SECTION 1.1. The Merger. At the Effective Time and upon the<br \/>\nterms and subject to the conditions of this Agreement and in accordance with the<br \/>\nDelaware General Corporation Law (the &#8220;DGCL&#8221;), the Company shall be merged with<br \/>\nand into Acquisition (the &#8220;Merger&#8221;). Following the Merger, Acquisition shall<br \/>\ncontinue as the surviving corporation (the &#8220;Surviving Corporation&#8221;) and the<br \/>\nseparate corporate existence of the Company shall cease.<\/p>\n<p>                  SECTION 1.2. Effective Time. Subject to the provisions of this<br \/>\nAgreement, Parent, Acquisition and the Company shall cause the Merger to be<br \/>\nconsummated by filing an appropriate Certificate of Merger or other appropriate<br \/>\ndocuments (the&#8221;Certificate of Merger&#8221;) with the Secretary of State of the State<br \/>\nof Delaware in such form as required by, and executed in accordance with, the<br \/>\nrelevant provisions of the DGCL, as soon as practicable on or after the Closing<br \/>\nDate (as defined in Section 1.3). The Merger shall become effective upon such<br \/>\nfiling or at such time thereafter as is provided in the Certificate of Merger<br \/>\n(the &#8220;Effective Time&#8221;).<\/p>\n<p>                  SECTION 1.3. Closing of the Merger. The closing of the Merger<br \/>\n(the &#8220;Closing&#8221;) will take place at a time and on a date to be specified by the<br \/>\nparties, which shall be no later than the second business day after satisfaction<br \/>\nor waiver of the conditions set forth in Article 5, other than those conditions<br \/>\nthat by their nature are to be satisfied at the Closing, but subject to the<br \/>\nfulfillment or waiver of those conditions (the &#8220;Closing Date&#8221;), at the offices<br \/>\nof Weil, Gotshal &amp; Manges LLP, 767 Fifth Avenue, New York, New York 10153,<br \/>\nunless another time, date or place is agreed to in writing by the parties<br \/>\nhereto.<\/p>\n<p>                  SECTION 1.4. Effects of the Merger. The Merger shall have the<br \/>\neffects set forth in the DGCL. Without limiting the generality of the foregoing,<br \/>\nand subject thereto, at the Effective Time, all the properties, rights,<br \/>\nprivileges, powers and franchises of the Company and Acquisition shall vest in<br \/>\nthe Surviving Corporation, and all debts, liabilities and duties of the Company<br \/>\nand Acquisition shall become the debts, liabilities and duties of the Surviving<br \/>\nCorporation.<\/p>\n<p>                  SECTION 1.5. Certificate of Incorporation and Bylaws. The<br \/>\ncertificate of incorporation of Acquisition in effect at the Effective Time<br \/>\nshall be the certificate of incorporation of the Surviving Corporation until<br \/>\namended in accordance with applicable law. The bylaws of Acquisition in effect<br \/>\nat the Effective Time shall be the bylaws of the Surviving Corporation until<br \/>\namended in accordance with applicable law.<\/p>\n<p>                  SECTION 1.6. Directors. The directors of Acquisition at the<br \/>\nEffective Time shall be the initial directors of the Surviving Corporation, each<br \/>\nto hold office in accordance with the certificate of incorporation and bylaws of<br \/>\nthe Surviving Corporation until such director&#8217;s successor is duly elected or<br \/>\nappointed and qualified.<\/p>\n<p>                  SECTION 1.7. Officers. The officers of Acquisition at the<br \/>\nEffective Time shall be the initial officers of the Surviving Corporation, each<br \/>\nto hold office in accordance with the certificate of incorporation and bylaws of<br \/>\nthe Surviving Corporation until such officer&#8217;s successor is duly elected or<br \/>\nappointed and qualified. The officers of the Company at the Effective Time shall<br \/>\nbe the initial officers of the Ventritex division of the Surviving Corporation,<br \/>\neach to hold such position in accordance with the certificate of incorporation<br \/>\nand bylaws of the Surviving Corporation until such person&#8217;s successor is duly<br \/>\nappointed and qualified.<\/p>\n<p>                  SECTION 1.8. Conversion of Shares.<\/p>\n<p>                  (a) At the Effective Time, each share of common stock, par<br \/>\nvalue $0.001 per share, of the Company (&#8220;Company Common Stock&#8221;) issued and<br \/>\noutstanding immediately prior to the Effective Time (individually a &#8220;Share&#8221; and<br \/>\ncollectively, the Shares&#8221;) (other than Shares held by Parent, Acquisition or any<br \/>\nother subsidiary of Parent) shall, by virtue of the Merger and without any<br \/>\naction on the part of Acquisition, the Company or the holder thereof, be<br \/>\nconverted into and shall become exchangeable for 0.6 of a fully paid and<br \/>\nnonassessable share of common stock, par value $0.10 per share, of Parent<br \/>\n(&#8220;Parent Common Stock&#8221;) (the &#8220;Exchange Ratio&#8221;). If between the date of this<br \/>\nAgreement and the Effective Time the outstanding shares of Parent Common Stock<br \/>\nshall have been changed into a different number of shares or a different class<br \/>\nby reason of any stock dividend, subdivision, reclassification,<br \/>\nrecapitalization, split, combination or exchange of shares, the amount of shares<br \/>\nof Parent Common Stock constituting the Exchange Ratio shall be correspondingly<br \/>\nadjusted to reflect such stock dividend, subdivision, reclassification,<br \/>\nrecapitalization, split, combination, exchange of shares or other similar<br \/>\ntransaction.<\/p>\n<p>                  (b) At the Effective Time, each outstanding share of the<br \/>\ncommon stock, par value $1.00 per share, of Acquisition shall remain outstanding<br \/>\nas one share of common stock, par value $1.00 per share, of the Surviving<br \/>\nCorporation.<\/p>\n<p>                  (c) At the Effective Time, each Share held by Parent,<br \/>\nAcquisition or any subsidiary of Parent or Acquisition immediately prior to the<br \/>\nEffective Time shall, by virtue of the Merger and without any action on the part<br \/>\nof Acquisition, the Company or the holder thereof, be canceled, retired and<br \/>\ncease to exist and no payment shall be made with respect thereto.<\/p>\n<p>                  (d) In accordance with Section 262 of the DGCL, no appraisal<br \/>\nrights shall be available to holders of Shares in connection with the Merger.<\/p>\n<p>                  SECTION 1.9. Exchange of Certificates.<\/p>\n<p>                  (a) As of the Effective Time, Parent shall make available to<br \/>\nAmerican Stock Transfer &amp; Trust Company (the &#8220;Exchange Agent&#8221;), for the benefit<br \/>\nof the holders of Shares, for exchange in accordance with this Article 1,<br \/>\nthrough the Exchange Agent: (i) certificates representing the appropriate number<br \/>\nof shares of Parent Common Stock issuable pursuant to Section 1.8 in exchange<br \/>\nfor outstanding Shares and (ii) cash to be paid in lieu of fractional shares of<br \/>\nParent Common Stock pursuant to Section 1.9(f) (such shares of Parent Common<br \/>\nStock and such cash are hereinafter referred to as the &#8220;Exchange Fund&#8221;).<\/p>\n<p>                  (b) As soon as reasonably practicable after the Effective<br \/>\nTime, the Exchange Agent shall mail to each holder of record of a certificate or<br \/>\ncertificates which immediately prior to the Effective Time represented<br \/>\noutstanding Shares (the &#8220;Certificates&#8221;) whose Shares were converted into the<br \/>\nright to receive shares of Parent Common Stock pursuant to Section 1.8: (i) a<br \/>\nletter of transmittal (which shall specify that delivery shall be effected, and<br \/>\nrisk of loss and title to the Certificates shall pass, only upon delivery of the<br \/>\nCertificates to the Exchange Agent and shall be in such form and have such other<br \/>\nprovisions as Parent and the Company may reasonably specify) and (ii)<br \/>\ninstructions for use in effecting the surrender of the Certificates in exchange<br \/>\nfor certificates representing shares of Parent Common Stock. Upon surrender of a<br \/>\nCertificate for cancellation to the Exchange Agent or to such other agent or<br \/>\nagents as may be appointed by Parent and Acquisition, together with such letter<br \/>\nof transmittal, duly executed, the holder of such Certificate shall be entitled<br \/>\nto receive in exchange therefor a certificate representing that number of whole<br \/>\nshares of Parent Common Stock and, if applicable, a check representing the cash<br \/>\nconsideration to which such holder may be entitled pursuant to Section 1.9(f) on<br \/>\naccount of a fractional share of Parent Common Stock, which such holder has the<br \/>\nright to receive pursuant to the provisions of this Article 1, and the<br \/>\nCertificate so surrendered shall forthwith be canceled. In the event of a<br \/>\ntransfer of ownership of Shares which is not registered in the transfer records<br \/>\nof the Company, a certificate representing the proper number of shares of Parent<br \/>\nCommon Stock may be issued to a transferee if the Certificate representing such<br \/>\nShares is presented to the Exchange Agent, accompanied by all documents required<br \/>\nto evidence and effect such transfer and by evidence that any applicable stock<br \/>\ntransfer taxes have been paid. Until surrendered as contemplated by this Section<br \/>\n1.9, each Certificate shall be deemed at any time after the Effective Time to<br \/>\nrepresent only the right to receive upon such surrender the certificate<br \/>\nrepresenting shares of Parent Common Stock and cash in lieu of any fractional<br \/>\nshares of Parent Common Stock as contemplated by this Section 1.9. Holders of<br \/>\nunsurrendered Certificates shall be entitled to vote after the Effective Time at<br \/>\nany meeting of Parent stockholders the number of whole shares of Parent Common<br \/>\nStock represented by such Certificates, regardless of whether such holders have<br \/>\nexchanged their Certificates.<\/p>\n<p>                  (c) No dividends or other distributions declared or made after<br \/>\nthe Effective Time with respect to Parent Common Stock with a record date after<br \/>\nthe Effective Time shall be paid to the holder of any unsurrendered Certificate<br \/>\nwith respect to the shares of Parent Common Stock represented thereby and no<br \/>\ncash payment in lieu of fractional shares shall be paid to any such holder<br \/>\npursuant to Section 1.9(f) until the holder of record of such Certificate shall<br \/>\nsurrender such Certificate. Subject to the effect of applicable laws, following<br \/>\nsurrender of any such Certificate, there shall be paid to the record holder of<br \/>\nthe certificates representing whole shares of Parent Common Stock issued in<br \/>\nexchange therefor, without interest, (i) at the time of such surrender, the<br \/>\namount of any cash payable in lieu of a fractional share of Parent Common Stock<br \/>\nto which such holder is entitled pursuant to Section 1.9(f) and the amount of<br \/>\ndividends or other distributions with a record date after the Effective Time<br \/>\ntheretofore paid with respect to such whole shares of Parent Common Stock, and<br \/>\n(ii) at the appropriate payment date, the amount of dividends or other<br \/>\ndistributions with a record date after the Effective Time but prior to surrender<br \/>\nand a payment date subsequent to surrender payable with respect to such whole<br \/>\nshares of Parent Common Stock.<\/p>\n<p>                  (d) In the event that any Certificate for Shares shall have<br \/>\nbeen lost, stolen or destroyed, the Exchange Agent shall issue in exchange<br \/>\ntherefor, upon the making of an affidavit of that fact by the holder thereof,<br \/>\nsuch shares of Parent Common Stock and cash in lieu of fractional shares, if<br \/>\nany, as may be required pursuant to this Agreement; PROVIDED, HOWEVER, that<br \/>\nParent may, in its discretion, require the delivery of a suitable bond or<br \/>\nindemnity.<\/p>\n<p>                  (e) All shares of Parent Common Stock issued upon the<br \/>\nsurrender for exchange of Shares in accordance with the terms hereof (including<br \/>\nany cash paid pursuant to Section 1.9(c) or 1.9(f)) shall be deemed to have been<br \/>\nissued in full satisfaction of all rights pertaining to such Shares, and there<br \/>\nshall be no further registration of transfers on the stock transfer books of the<br \/>\nSurviving Corporation of the Shares which were outstanding immediately prior to<br \/>\nthe Effective Time. If, after the Effective Time, Certificates are presented to<br \/>\nthe Surviving Corporation for any reason, they shall be canceled and exchanged<br \/>\nas provided in this Article I.<\/p>\n<p>                  (f) No fractions of a share of Parent Common Stock shall be<br \/>\nissued in the Merger, but in lieu thereof each holder of Shares otherwise<br \/>\nentitled to a fraction of a share of Parent Common Stock shall, upon surrender<br \/>\nof his or her Certificate or Certificates, be entitled to receive an amount of<br \/>\ncash (without interest) determined by multiplying the average closing price for<br \/>\nParent Common Stock as reported on the Nasdaq Stock Market (or any subsequent<br \/>\nnational securities exchange on which shares of Parent Common Stock are listed<br \/>\nfor trading) for the five trading days immediately preceding the date of the<br \/>\nmeeting of the Company&#8217;s stockholders held in connection with the Merger by the<br \/>\nfractional share interest to which such holder would otherwise be entitled. The<br \/>\nparties acknowledge that payment of the cash consideration in lieu of issuing<br \/>\nfractional shares was not separately bargained for consideration but merely<br \/>\nrepresents a mechanical rounding off for purposes of simplifying the corporate<br \/>\nand accounting problems which would otherwise be caused by the issuance of<br \/>\nfractional shares.<\/p>\n<p>                  (g) Any portion of the Exchange Fund which remains<br \/>\nundistributed to the stockholders of the Company for six months after the<br \/>\nEffective Time shall be delivered to Parent, upon demand, and any stockholders<br \/>\nof the Company who have not theretofore complied with this Article I shall<br \/>\nthereafter look only to Parent for payment of their claim for Parent Common<br \/>\nStock for any cash in lieu of fractional shares of Parent Common Stock and any<br \/>\ndividends or distributions with respect to Parent Common Stock, as the case may<br \/>\nbe.<\/p>\n<p>                  (h) Neither Parent nor the Company shall be liable to any<br \/>\nholder of Shares, or Parent Common Stock, as the case may be, for such shares<br \/>\n(or dividends or distributions with respect thereto) or cash from the Exchange<br \/>\nFund delivered to a public official pursuant to any applicable abandoned<br \/>\nproperty, escheat or similar law.<\/p>\n<p>                  SECTION 1.10. Stock Options.<\/p>\n<p>                  (a) At the Effective Time, each outstanding option to purchase<br \/>\nshares of Company Common Stock (a &#8220;Company Stock Option&#8221; or, collectively,<br \/>\n&#8220;Company Stock Options&#8221;) issued pursuant to the Company&#8217;s stock option plans<br \/>\nlisted on Schedule 1.10 hereto (the &#8220;Company Plans&#8221;), whether vested or<br \/>\nunvested, shall be cancelled and, in lieu thereof, Parent shall issue to each<br \/>\nholder of a Company Stock Option an option (each, a &#8220;Parent Option&#8221;), to<br \/>\nacquire, on substantially the same terms and subject to substantially the same<br \/>\nconditions as were applicable under such Company Stock Option, including,<br \/>\nwithout limitation, term, exercisability, vesting schedule, status as an<br \/>\n&#8220;incentive stock option&#8221; under Section 422 of the Code, acceleration and<br \/>\ntermination provisions, the same number of shares of Parent Common Stock as the<br \/>\nholder of such Company Stock Option would have been entitled to receive pursuant<br \/>\nto the Merger had such holder exercised such option in full immediately prior to<br \/>\nthe Effective Time, at a price per share equal to (y) the aggregate exercise<br \/>\nprice for the shares of Company Common Stock otherwise purchasable pursuant to<br \/>\nsuch Company Stock Option divided by (z) the number of full shares of Parent<br \/>\nCommon Stock deemed purchasable pursuant to such Company Stock Option; provided,<br \/>\nhowever, that in the case of any option to which Section 421 of the Code applies<br \/>\nby reason of its qualification under any of Sections 422 through 424 of the<br \/>\nCode, the exercise price, the number of shares purchasable pursuant to such<br \/>\noption and the terms and conditions of exercise of such option shall be<br \/>\nadjusted, if necessary, in order to comply with Section 424 of the Code and<br \/>\nprovided, further, however, that the number of shares of Parent Common Stock<br \/>\nthat may be purchased upon exercise of any such Parent Option shall not include<br \/>\nany fractional share and, upon exercise of the Parent Option, a cash payment<br \/>\nshall be made for any fractional share based upon the average closing price for<br \/>\nParent Common Stock as reported on the Nasdaq Stock Market (or any subsequent<br \/>\nnational securities exchange on which shares of Parent Common Stock are listed<br \/>\nfor trading) for the five trading days immediately preceding the<br \/>\ndate of exercise. Employment with the Company shall be credited to the optionees<br \/>\nfor purposes of determining the number of vested shares of Parent Common Stock<br \/>\nsubject to exercise under converted Company Options after the Effective Time.<br \/>\nNone of the Company Stock Options that are unvested at the Effective Time shall<br \/>\nbecome vested as a result of the execution and delivery of this Agreement or the<br \/>\nconsummation of the Merger.<\/p>\n<p>                  (b) As soon as practicable after the Effective Time, but no<br \/>\nlater than 30 days thereafter, Parent shall deliver to the holders of Company<br \/>\nStock Options appropriate notices setting forth such holders&#8217; rights pursuant to<br \/>\nthe respective Company Plans and stating that the holders will receive Parent<br \/>\nOptions exercisable for shares of Parent Common Stock on substantially the same<br \/>\nterms and conditions as their Company Stock Options (subject to the adjustments<br \/>\nrequired by this Section 1.10 after giving effect to the Merger). At or prior to<br \/>\nthe Effective Time, Parent shall take all corporate action necessary to reserve<br \/>\nfor issuance a sufficient number of shares of Parent Common Stock for delivery<br \/>\nupon exercise of Parent Options issued by it in accordance with this Section<br \/>\n1.10. As soon as practicable after the Effective Time, to the extent the Parent<br \/>\nCommon Stock issuable upon exercise of the Parent Options issued in accordance<br \/>\nwith this Section 1.10 has not previously been registered under the Securities<br \/>\nAct of 1933, as amended (the &#8220;Securities Act&#8221;), then Parent shall file a<br \/>\nregistration statement on Form S-3 or Form S-8, as the case may be (or any<br \/>\nsuccessor or other appropriate forms), or another appropriate form with respect<br \/>\nto the Parent Common Stock subject to such Parent Options, and shall use its<br \/>\nbest efforts to maintain the effectiveness of such registration statements (and<br \/>\nmaintain the current status of the prospectus or prospectuses contained therein)<br \/>\nfor so long as the Parent Options remain outstanding.<\/p>\n<p>                                    ARTICLE 2<\/p>\n<p>                  REPRESENTATIONS AND WARRANTIES OF THE COMPANY<\/p>\n<p>                  The Company hereby represents and warrants to each of Parent<br \/>\nand Acquisition as follows:<\/p>\n<p>                  SECTION 2.1. Organization and Qualification; Subsidiaries.<\/p>\n<p>                  (a) The Company and each of its subsidiaries (as defined in<br \/>\nSection 7.10), is a corporation duly organized, validly existing and in good<br \/>\nstanding under the laws of the jurisdiction of its incorporation and has all<br \/>\nrequisite corporate power and authority to own, lease and operate its properties<br \/>\nand to carry on its businesses as now being conducted, except where the failure<br \/>\nto be so organized, existing and in good standing or to have such power and<br \/>\nauthority would not have a Company Material Adverse Effect (as defined below).<br \/>\nWhen used in connection with the Company or its subsidiaries, the term &#8220;Company<br \/>\nMaterial Adverse Effect&#8221; means any change or effect (i) that is materially<br \/>\nadverse to the properties, business, results of operations or financial<br \/>\ncondition of the Company and its subsidiaries, taken as whole, other than any<br \/>\nchange or effect arising out of general economic conditions or conditions<br \/>\ngenerally affecting the cardiovascular medical device market or (ii) that would<br \/>\nimpair the ability of the Company to consummate the transactions contemplated<br \/>\nhereby.<\/p>\n<p>                  (b) Except as set forth in Section 2.1(b) of the Disclosure<br \/>\nSchedule previously delivered by the Company to Parent (the &#8220;Company Disclosure<br \/>\nSchedule&#8221;), the Company has no subsidiaries and does not own, directly or<br \/>\nindirectly, beneficially or of record, any shares of capital stock or other<br \/>\nsecurity of any other entity or any other investment in any other entity.<\/p>\n<p>                  (c) Each of the Company and its subsidiaries is duly qualified<br \/>\nor licensed and in good standing to do business in each jurisdiction in which<br \/>\nthe property owned, leased or operated by it or the nature of the business<br \/>\nconducted by it makes such qualification or licensing necessary, except in such<br \/>\njurisdictions where the failure to be so duly qualified or licensed and in good<br \/>\nstanding would not have a Company Material Adverse Effect.<\/p>\n<p>                  (d) The Company has heretofore delivered to Parent accurate<br \/>\nand complete copies of the certificate of incorporation and by-laws, as<br \/>\ncurrently in effect, of each of the Company and each of its subsidiaries.<\/p>\n<p>                  SECTION 2.2. Capitalization of the Company and its<br \/>\nSubsidiaries.<\/p>\n<p>                  (a) The authorized capital stock of the Company consists of:<br \/>\n35,000,000 Shares, of which, as of October 15, 1996, 20,959,260 Shares were<br \/>\nissued and outstanding, and 5,000,000 shares of preferred stock, par value<br \/>\n$0.001 per share (the &#8220;Company Preferred Stock&#8221;), of which, as of the date<br \/>\nhereof, none are issued and outstanding. All of the issued and outstanding<br \/>\nShares have been validly issued, and are fully paid, nonassessable and free of<br \/>\npreemptive rights. As of October 15, 1996, 2,782,116 Shares were reserved for<br \/>\nissuance and issuable upon or otherwise deliverable in connection with the<br \/>\nexercise of outstanding Company Stock Options issued pursuant to the Company<br \/>\nPlans, 78,813 Shares were reserved for issuance under the Company&#8217;s 1991<br \/>\nEmployee Stock Purchase Plan (the &#8220;ESPP&#8221;) and 3,345,455 Shares were reserved for<br \/>\nissuance pursuant to the conversion of the Company&#8217;s 5-3\/4% Convertible<br \/>\nSubordinated Notes due August 15, 2001 (the &#8220;Convertible Notes&#8221;). The final<br \/>\npurchase by participants under the ESPP will occur no later than the business<br \/>\nday immediately preceding the Effective Time. The ESPP will terminate at the<br \/>\nEffective Time. A total of 35,000 shares of Preferred Stock have been designated<br \/>\nas Series A Participating Preferred Stock and reserved for issuance in<br \/>\nconnection with the exercise of the Rights (as defined in Section 2.20). Except<br \/>\nas set forth in Section 2.2(a) of the Company Disclosure Schedule, since October<br \/>\n15, 1996, no shares of the Company&#8217;s capital stock have been issued other than<br \/>\npursuant to stock options already in existence on October 15, 1996, and no stock<br \/>\noptions have been granted. Except as set forth above or as set forth in Section<br \/>\n2.2(a) of the Company Disclosure Schedule, as of the date hereof, there are<br \/>\noutstanding (i) no shares of capital stock or other voting securities of the<br \/>\nCompany, (ii) no securities of the Company or its subsidiaries convertible into<br \/>\nor exchangeable for shares of capital stock or voting securities of the Company,<br \/>\n(iii) no options or other rights to acquire from the Company or its<br \/>\nsubsidiaries, and no obligations of the Company or its subsidiaries to issue,<br \/>\nany capital stock, voting securities or securities convertible into or<br \/>\nexchangeable for capital stock or voting securities of the Company, and (iv) no<br \/>\nequity equivalents, interests in the ownership or earnings of the Company or its<br \/>\nsubsidiaries or other similar rights (including stock appreciation rights)<br \/>\n(collectively, &#8220;Company Securities&#8221;). There are no outstanding obligations of<br \/>\nthe Company or its subsidiaries to repurchase, redeem or otherwise acquire any<br \/>\nCompany Securities. Except as set forth in Section 2.2(a) of the Company<br \/>\nDisclosure Schedule, there are no stockholder agreements, voting trusts or other<br \/>\nagreements or understandings to which the Company is a party or to which it is<br \/>\nbound relating to the voting of any shares of capital stock of the Company.<\/p>\n<p>                  (b) All of the outstanding capital stock of the Company&#8217;s<br \/>\nsubsidiaries is owned by the Company, directly or indirectly, free and clear of<br \/>\nany Lien (as defined below) or any other limitation or restriction (including<br \/>\nany restriction on the right to vote or sell the same, except as may be provided<br \/>\nas a matter of law). There are no securities of the Company or its subsidiaries<br \/>\nconvertible into or exchangeable for, no options or other rights to acquire from<br \/>\nthe Company or its subsidiaries, and no other contract, understanding,<br \/>\narrangement or obligation (whether or not contingent) providing for the issuance<br \/>\nor sale, directly or indirectly, of any capital stock or other ownership<br \/>\ninterests in, or any other securities of, any subsidiary of the Company. There<br \/>\nare no outstanding contractual obligations of the Company or its subsidiaries to<br \/>\nrepurchase, redeem or otherwise acquire any outstanding shares of capital stock<br \/>\nor other ownership interests in any subsidiary of the Company. For purposes of<br \/>\nthis Agreement, &#8220;Lien&#8221; means, with respect to any asset (including, without<br \/>\nlimitation, any security) any mortgage, lien, pledge, charge, security interest<br \/>\nor encumbrance of any kind in respect of such asset.<\/p>\n<p>                  SECTION 2.3. Authority Relative to this Agreement.<\/p>\n<p>                  (a) The Company has all necessary corporate power and<br \/>\nauthority to execute and deliver this Agreement and to consummate the<br \/>\ntransactions contemplated hereby. The execution and delivery of this Agreement<br \/>\nand the consummation of the transactions contemplated hereby have been duly and<br \/>\nvalidly authorized by the Board of Directors of the Company (the &#8220;Company<br \/>\nBoard&#8221;) and no other corporate proceedings on the part of the Company are<br \/>\nnecessary to authorize this Agreement or to consummate the transactions<br \/>\ncontemplated hereby (other than, with respect to the Merger, the approval and<br \/>\nadoption of this Agreement by the holders of a majority of the then outstanding<br \/>\nshares of Company Common Stock). This Agreement has been duly and validly<br \/>\nexecuted and delivered by the Company and constitutes a valid, legal and binding<br \/>\nagreement of the Company, enforceable against the Company in accordance with its<br \/>\nterms, subject to bankruptcy, insolvency, fraudulent transfer, reorganization,<br \/>\nmoratorium and similar laws of general applicability relating to or affecting<br \/>\ncreditors&#8217; rights and to general equity principles (the &#8220;Bankruptcy and Equity<br \/>\nException&#8221;).<\/p>\n<p>                  (b) The Company Board has, by unanimous vote of those present,<br \/>\nduly and validly approved, and taken all corporate actions required to be taken<br \/>\nby the Company Board for the consummation of, the transactions, including the<br \/>\nMerger, contemplated hereby and resolved to recommend that the stockholders of<br \/>\nthe Company approve and adopt this Agreement.<\/p>\n<p>                  SECTION 2.4. SEC Reports; Financial Statements.<\/p>\n<p>                  (a) The Company has filed all required forms, reports and<br \/>\ndocuments with the Securities and Exchange Commission (the &#8220;SEC&#8221;) since January<br \/>\n1, 1995, each of which has complied in all material respects with all applicable<br \/>\nrequirements of the Securities Act and the Securities Exchange Act of 1934, as<br \/>\namended (the &#8220;Exchange Act&#8221;), each as in effect on the dates such forms, reports<br \/>\nand documents were filed. The Company has heretofore delivered to Parent, in the<br \/>\nform filed with the SEC (including any amendments thereto), (i) its Annual<br \/>\nReport on Form 10-K for the fiscal year ended June 30, 1996, (ii) all definitive<br \/>\nproxy statements relating to the Company&#8217;s meetings of stockholders (whether<br \/>\nannual or special) held since July 1, 1995 and (iii) all other reports or<br \/>\nregistration statements filed by the Company with the SEC since January 1, 1995<br \/>\n(the &#8220;Company SEC Reports&#8221;). As of their respective dates, none of such Company<br \/>\nSEC Reports contained any untrue statement of a material fact or omitted to<br \/>\nstate a material fact required to be stated or incorporated by reference therein<br \/>\nor necessary in order to make the statements therein, in light of the<br \/>\ncircumstances under which they were made, not misleading. The consolidated<br \/>\nfinancial statements of the Company included in the Company SEC Reports complied<br \/>\nas to form in all material respects with applicable accounting requirements and<br \/>\nthe published rules and regulations of the SEC with respect thereto and fairly<br \/>\npresent, in conformity with generally accepted accounting principles (&#8220;GAAP&#8221;)<br \/>\napplied on a consistent basis (except as may be indicated in the notes thereto),<br \/>\nthe consolidated financial position of the Company and its consolidated<br \/>\nsubsidiaries as of the dates thereof and their consolidated results of<br \/>\noperations and changes in financial position for the periods then ended<br \/>\n(subject, in the case of the unaudited interim financial statements, to normal<br \/>\nyear-end adjustments). Since June 30, 1996, except as set forth in the Company<br \/>\nSEC Reports, there has not been any change, or any application or request for<br \/>\nany change, by the Company or any of its subsidiaries in accounting principles,<br \/>\nmethods or policies for financial accounting or tax purposes (subject, in the<br \/>\ncase of the unaudited interim financial statements, to normal year-end<br \/>\nadjustments).<\/p>\n<p>                  (b) The Company has heretofore made available to Parent a<br \/>\ncomplete and correct copy of any material amendments or modifications, which<br \/>\nhave not yet been filed with the SEC, to agreements, documents or other<br \/>\ninstruments which previously had been filed by the Company with the SEC pursuant<br \/>\nto the Exchange Act.<\/p>\n<p>                  SECTION 2.5. Information Supplied. None of the information<br \/>\nsupplied or to be supplied by the Company for inclusion or incorporation by<br \/>\nreference in (i) the registration statement on Form S-4 to be filed with the SEC<br \/>\nby Parent in connection with the issuance of shares of Parent Common Stock in<br \/>\nthe Merger (the &#8220;S-4&#8221;) will, at the time the S-4 is filed with the SEC and at<br \/>\nthe time it becomes effective under the Securities Act, contain any untrue<br \/>\nstatement of a material fact or omit to state any material fact required to be<br \/>\nstated therein or necessary to make the statements therein not misleading, and<br \/>\n(ii) the proxy statement relating to the meeting of the Company&#8217;s stockholders<br \/>\nto be held in connection with the Merger (the &#8220;Proxy Statement&#8221;), will, at the<br \/>\ndate mailed to stockholders and at the time of the meeting of stockholders of<br \/>\nthe Company to be held in connection with the Merger, contain any untrue<br \/>\nstatement of a material fact or omit to state any material fact required to be<br \/>\nstated therein or necessary in order to make the statements therein, in light of<br \/>\nthe circumstances under which they are made, not misleading. If at any time<br \/>\nprior to the Effective Time any event with respect to the Company, its officers<br \/>\nand directors or any of its subsidiaries should occur which is required to be<br \/>\ndescribed in an amendment of, or a supplement to, the S-4 or the Proxy<br \/>\nStatement, the Company shall promptly so advise Parent and such event shall be<br \/>\nso described, and such amendment or supplement (which Parent shall have a<br \/>\nreasonable opportunity to review) shall be promptly filed with the SEC and, as<br \/>\nrequired by law, disseminated to the stockholders of the Company. The Proxy<br \/>\nStatement, insofar as it relates to the meeting of the Company&#8217;s stockholders to<br \/>\nvote on the Merger, will comply as to form in all material respects with the<br \/>\nprovisions of the Exchange Act and the rules and regulations thereunder.<\/p>\n<p>                  SECTION 2.6. Consents and Approvals; No Violations. Except for<br \/>\nfilings, permits, authorizations, consents and approvals as may be required<br \/>\nunder, and other applicable requirements of, the Securities Act, the Exchange<br \/>\nAct, state securities or blue sky laws, the Hart-Scott-Rodino Antitrust<br \/>\nImprovements Act of 1976, as amended (the &#8220;HSR Act&#8221;), the filing and recordation<br \/>\nof the Certificate of Merger as required by the DGCL and as otherwise set forth<br \/>\nin Section 2.6 to the Company Disclosure Schedule, no filing or registration<br \/>\nwith or notice to, and no permit, authorization, consent or approval of, any<br \/>\ncourt or tribunal or administrative, governmental or regulatory body, agency,<br \/>\ncommission or authority (a &#8220;Governmental Entity&#8221;) is necessary for the execution<br \/>\nand delivery by the Company of this Agreement or the consummation by the Company<br \/>\nof the transactions contemplated hereby, except where the failure to obtain such<br \/>\npermits, authorizations, consents or approvals or to make such filings or give<br \/>\nsuch notice would not have a Company Material Adverse Effect. Except as set<br \/>\nforth in Section 2.6 to the Company Disclosure Schedule, neither the execution,<br \/>\ndelivery and performance of this Agreement by the Company nor the consummation<br \/>\nby the Company of the transactions contemplated hereby will (i) conflict with or<br \/>\nresult in any breach of any provision of the respective certificate or articles<br \/>\nof incorporation or bylaws (or similar governing documents) of the Company or<br \/>\nany of its subsidiaries, (ii) result in a violation or breach of, or constitute<br \/>\n(with or without due notice or lapse of time or both) a default (or give rise to<br \/>\nany right of termination, amendment, cancellation or acceleration or Lien)<br \/>\nunder, any of the terms, conditions or provisions of any note, bond, mortgage,<br \/>\nindenture, lease, license, contract, agreement or other instrument or obligation<br \/>\nto which the Company or any of its subsidiaries is a party or by which any of<br \/>\nthem or any of their respective properties or assets may be bound, or (iii)<br \/>\nviolate any order, writ, injunction, decree, law, statute, rule or regulation<br \/>\napplicable to the Company or any of its subsidiaries or any of their respective<br \/>\nproperties or assets, except in the case of (ii) or (iii) for violations,<br \/>\nbreaches or defaults which would not have a Company Material Adverse Effect.<\/p>\n<p>                  SECTION 2.7. No Default. None of the Company or its<br \/>\nsubsidiaries is in default or violation (and no event has occurred which with<br \/>\nnotice or the lapse of time or both would constitute a default or violation) of<br \/>\nany term, condition or provision of (i) its certificate or articles of<br \/>\nincorporation or bylaws (or similar governing documents), (ii) any note, bond,<br \/>\nmortgage, indenture, lease, license, contract, agreement or other instrument or<br \/>\nobligation to which the Company or any of its subsidiaries is now a party or by<br \/>\nwhich any of them or any of their respective properties or assets may be bound<br \/>\nor (iii) any order, writ, injunction, decree, law, statute, rule or regulation<br \/>\napplicable to the Company, its subsidiaries or any of their respective<br \/>\nproperties or assets, except in the case of (ii) or (iii) for violations,<br \/>\nbreaches or defaults that would not have a Company Material Adverse Effect.<\/p>\n<p>                  SECTION 2.8. No Undisclosed Liabilities; Absence of Changes.<br \/>\nExcept as and to the extent publicly disclosed by the Company in the Company SEC<br \/>\nReports, as of June 30, 1996, none of the Company or its subsidiaries had any<br \/>\nliabilities or obligations of any nature, whether or not accrued, contingent or<br \/>\notherwise, and whether due or to become due or asserted or unasserted, which<br \/>\nwould be required by GAAP to be reflected in, reserved against or otherwise<br \/>\ndescribed in the consolidated balance sheet of the Company (including the notes<br \/>\nthereto) as of such date. Except as publicly disclosed by the Company in the<br \/>\nCompany SEC Reports, since the date of the end of the period covered by the<br \/>\nlatest Company SEC Report, (i) the business of the Company and its subsidiaries<br \/>\nhas been carried on only in the ordinary and usual course, and (ii) to the<br \/>\nknowledge of the Company, none of the Company or its subsidiaries has incurred<br \/>\nany liabilities of any nature, whether or not accrued, contingent or otherwise,<br \/>\nand there have been no events, changes or effects with respect to the Company or<br \/>\nits subsidiaries, which would have a Company Material Adverse Effect. For<br \/>\npurposes of this Agreement, &#8220;knowledge of the Company&#8221; means the actual<br \/>\nknowledge of any executive officer or member of the Company Board as listed in<br \/>\nSection 2.8 of the Company Disclosure Schedule.<\/p>\n<p>                  SECTION 2.9. Litigation. Except as publicly disclosed by the<br \/>\nCompany in the Company SEC Reports or disclosed in Section 2.9 of the Company<br \/>\nDisclosure Schedule, there is no suit, claim, action, proceeding or<br \/>\ninvestigation pending or, to the knowledge of the Company, threatened against<br \/>\nthe Company or any of its subsidiaries or any of their respective properties or<br \/>\nassets which (i) would have, individually or in the aggregate, a Company<br \/>\nMaterial Adverse Effect or (ii) as of the date hereof, questions the validity of<br \/>\nthis Agreement or any action to be taken by the Company in connection with the<br \/>\nconsummation of the transactions contemplated hereby or could otherwise prevent<br \/>\nor delay the consummation of the transactions contemplated by this Agreement.<br \/>\nExcept as publicly disclosed by the Company, none of the Company or its<br \/>\nsubsidiaries is subject to any outstanding order, writ, injunction or decree<br \/>\nwhich would have a Company Material Adverse Effect or would prevent or delay the<br \/>\nconsummation of the transactions contemplated hereby.<\/p>\n<p>                  SECTION 2.10. Compliance with Applicable Law. Except as<br \/>\npublicly disclosed by the Company in the Company SEC Reports, the Company and<br \/>\nits subsidiaries hold all permits, licenses, variances, exemptions, orders and<br \/>\napprovals of all Governmental Entities necessary for the conduct of their<br \/>\nrespective businesses as presently conducted (the &#8220;Company Permits&#8221;), except for<br \/>\nfailures to hold such permits, licenses, variances, exemptions, orders and<br \/>\napprovals which would not have a Company Material Adverse Effect. Except as<br \/>\npublicly disclosed by the Company in the Company SEC Reports, the Company and<br \/>\nits subsidiaries are in compliance with the terms of the Company Permits, except<br \/>\nwhere the failure so to comply would have a Company Material Adverse Effect.<br \/>\nExcept as publicly disclosed by the Company in the Company SEC Reports, the<br \/>\nbusinesses of the Company and its subsidiaries are not being conducted in<br \/>\nviolation of any law, ordinance or regulation of any Governmental Entity except<br \/>\nthat no representation or warranty is made in this Section 2.10 with respect to<br \/>\nEnvironmental Laws (as defined in Section 2.12(a)) and except for violations or<br \/>\npossible violations which would not have a Company Material Adverse Effect.<br \/>\nExcept as publicly disclosed by the Company in the Company SEC Reports or as<br \/>\ndisclosed in Section 2.10 of the Company Disclosure Schedule, to the knowledge<br \/>\nof the Company, no investigation or review by any Governmental Entity with<br \/>\nrespect to the Company or its subsidiaries is pending or threatened, nor, to the<br \/>\nknowledge of the Company, has any Governmental Entity indicated an intention to<br \/>\nconduct the same, other than, in each case, those which would not have a Company<br \/>\nMaterial Adverse Effect.<\/p>\n<p>                  SECTION 2.11. Employee Plans.<\/p>\n<p>                  (a) Section 2.11(a) of the Company Disclosure Schedule lists<br \/>\nall &#8220;employee benefit plans,&#8221; as defined in Section 3(3) of ERISA, and all other<br \/>\nemployee benefit plans or other benefit arrangements, including executive<br \/>\ncompensation, directors&#8217; benefit, bonus or other incentive compensation,<br \/>\nseverance and deferred compensation plans and practices which the Company or any<br \/>\nof its subsidiaries maintains, contributes to or has any obligation to or<br \/>\nliability for (each an &#8220;Employee Benefit Plan&#8221; and collectively, the &#8220;Employee<br \/>\nBenefit Plans&#8221;).<\/p>\n<p>                  (b) True, correct and complete copies or descriptions of each<br \/>\nEmployee Benefit Plan (and, where applicable, the most recent summary plan<br \/>\ndescription, actuarial report, determination letter, most recent Form 5500 and<br \/>\ntrust agreement) have been delivered or made available to Parent for review<br \/>\nprior to the date hereof.<\/p>\n<p>                  (c) As of the date hereof, except as disclosed on Section<br \/>\n2.11(c) of the Company Disclosure Schedule, (i) all material payments required<br \/>\nto be made by or under any Employee Benefit Plan or any related trusts have been<br \/>\nmade; (ii) the Company and its subsidiaries have performed all material<br \/>\nobligations required to be performed by them under any Employee Benefit Plan;<br \/>\n(iii) the Employee Benefit Plans, have been administered in material compliance<br \/>\nwith their terms and the requirements of ERISA, the Code and other applicable<br \/>\nlaws; (iv) there are no material actions, suits, arbitrations or claims (other<br \/>\nthan routine claims for benefit) pending or threatened with respect to any<br \/>\nEmployee Benefit Plan; and (v) the Company and its subsidiaries have no material<br \/>\nliability as a result of any &#8220;prohibited transaction&#8221; (as defined in Section 406<br \/>\nof ERISA and Section 4975 of the Code) for any excise tax or civil penalty.<\/p>\n<p>                  (d) Except as disclosed on Section 2.11(d) of the Company<br \/>\nDisclosure, none of the Employee Benefit Plans is subject to Title IV of ERISA.<\/p>\n<p>                  (e) Except as set forth on Section 2.11(e) of the Company<br \/>\nDisclosure Schedule, the Company and its subsidiaries have not incurred any<br \/>\nunsatisfied withdrawal liability with respect to any Multiemployer Plan.<\/p>\n<p>                  (f) Except as set forth on Section 2.11(f) of the Company<br \/>\nDisclosure Schedule, each of the Employee Benefit Plans which is intended to be<br \/>\n&#8220;qualified&#8221; within the meaning of Section 401(a) of the Code has been determined<br \/>\nby the Internal Revenue Service to be so &#8220;qualified&#8221; and the Company knows of no<br \/>\nfact which would adversely affect the qualified status of any such Employee<br \/>\nBenefit Plan.<\/p>\n<p>                  (g) Except as set forth on Section 2.11(g) of the Company<br \/>\nDisclosure Schedule, neither the execution and delivery of this Agreement nor<br \/>\nthe consummation of the transactions contemplated hereby will (i) result in any<br \/>\nmaterial payment becoming due, or materially increase the amount of compensation<br \/>\ndue, to any current or former employee of the Company or any of its<br \/>\nsubsidiaries; (ii) materially increase any benefits otherwise payable under any<br \/>\nEmployee Benefit Plan; or (iii) result in the acceleration of the time of<br \/>\npayment or vesting of any such material benefits.<\/p>\n<p>                  SECTION 2.12. Environmental Laws and Regulations.<\/p>\n<p>                  (a) Except as publicly disclosed by the Company in the Company<br \/>\nSEC Reports, (i) each of the Company and its subsidiaries is in compliance with<br \/>\nall applicable federal, state and local laws and regulations relating to<br \/>\npollution, the protection of human health from the effects of pollution or the<br \/>\nenvironment (including, without limitation, ambient air, surface water, ground<br \/>\nwater, land surface or subsurface strata) (collectively, &#8220;Environmental Laws&#8221;),<br \/>\nexcept for non-compliance that would not have a Company Material Adverse Effect,<br \/>\nwhich compliance includes, but is not limited to, the possession by the Company<br \/>\nand its subsidiaries of all material permits and other governmental<br \/>\nauthorizations required under applicable Environmental Laws necessary for the<br \/>\noperation of its business as presently conducted, and compliance with the terms<br \/>\nand conditions thereof; (ii) none of the Company or its subsidiaries has<br \/>\nreceived written notice of, or, to the knowledge of the Company, is the subject<br \/>\nof, any action, cause of action, claim, investigation, demand or notice by any<br \/>\nperson or entity alleging liability under or non-compliance with any<br \/>\nEnvironmental Law (an &#8220;Environmental Claim&#8221;) that would have a Company Material<br \/>\nAdverse Effect; and (iii) to the knowledge of the Company, there are no<br \/>\ncircumstances that are reasonably likely to prevent or interfere with such<br \/>\nmaterial compliance in the future.<\/p>\n<p>                  (b) Except as publicly disclosed by the Company in the Company<br \/>\nSEC Reports, there are no Environmental Claims which would have a Company<br \/>\nMaterial Adverse Effect that are pending or, to the knowledge of the Company,<br \/>\nthreatened against the Company or its subsidiaries or, to the knowledge of the<br \/>\nCompany, against any person or entity whose liability for any Environmental<br \/>\nClaim the Company or any of its subsidiaries has or may have retained or assumed<br \/>\neither contractually or by operation of law.<\/p>\n<p>                  SECTION 2.13. Tax Matters.<\/p>\n<p>                  (a) The Company and each of its subsidiaries has timely filed<br \/>\nall Federal income tax returns and all other material tax returns and reports<br \/>\nrequired to be filed by it. All such tax returns are complete and correct in all<br \/>\nmaterial respects. The Company and each of its subsidiaries has paid (or the<br \/>\nCompany has paid on its subsidiaries&#8217; behalf) all taxes shown due on such tax<br \/>\nreturns. The most recent consolidated financial statements contained in the<br \/>\nCompany SEC Reports reflect an adequate reserve for all taxes payable by the<br \/>\nCompany and its subsidiaries for all taxable periods and portions thereof<br \/>\nthrough the date of such financial statements. The Company has previously<br \/>\ndelivered to Parent copies of the Federal and California income tax returns<br \/>\nfiled by the Company for its taxable years ended in 1993, 1994 and 1995. For<br \/>\npurposes of this Agreement, &#8220;tax&#8221; or &#8220;taxes&#8221; shall mean all taxes, charges,<br \/>\nfees, imposts, levies, gaming or other assessments, including, without<br \/>\nlimitation, all net income, gross receipts, capital, sales, use, ad valorem,<br \/>\nvalue added, transfer, franchise, profits, inventory, capital stock, license,<br \/>\nwithholding, payroll, employment, social security, unemployment, excise,<br \/>\nseverance, stamp, occupation, property and estimated taxes, customs duties,<br \/>\nfees, assessments and charges of any kind whatsoever, together with any interest<br \/>\nand any penalties, fines, additions to tax or additional amounts imposed by any<br \/>\ntaxing authority (domestic or foreign). &#8220;Tax returns&#8221; shall mean any report,<br \/>\nreturn, document, declaration or any other information or filing required to be<br \/>\nsupplied to any taxing authority or jurisdiction (foreign or domestic) with<br \/>\nrespect to taxes, including without limitation, information returns, any<br \/>\ndocument with respect to or accompanying payments or estimated taxes, or with<br \/>\nrespect to or accompanying requests for the extension of time in which to file<br \/>\nany such report, return document, declaration or other information.<\/p>\n<p>                  (b) Except as disclosed on Section 2.13 of the Company<br \/>\nDisclosure Schedule, no material deficiencies for any taxes have been proposed,<br \/>\nasserted or assessed against the Company or any of its subsidiaries that have<br \/>\nnot been fully paid or adequately provided for in the appropriate financial<br \/>\nstatements of the Company and its subsidiaries, no requests for waivers of the<br \/>\ntime to assess any taxes are pending, and no power of attorney with respect to<br \/>\nany taxes has been executed or filed with any taxing authority. No material<br \/>\nissues relating to taxes have been raised in writing by the relevant taxing<br \/>\nauthority during any presently pending audit or examination. None of the Federal<br \/>\nincome tax returns of the Company or any of its subsidiaries consolidated in<br \/>\nsuch tax returns has been examined by the Internal Revenue Service.<\/p>\n<p>                  (c) No material liens for taxes exist with respect to any<br \/>\nassets or properties of the Company or any of its subsidiaries, except for<br \/>\nstatutory liens for taxes not yet due.<\/p>\n<p>                  (d) Except as disclosed on Section 2.13 of the Company<br \/>\nDisclosure Schedule and other than with respect to contractual tax indemnity<br \/>\nobligations of the Company and its subsidiaries involving claims for state and<br \/>\nlocal taxes which are not material in amount, none of the Company or any of its<br \/>\nsubsidiaries is a party to or is bound by any tax sharing agreement, tax<br \/>\nindemnity obligation or similar agreement, arrangement or practice with respect<br \/>\nto taxes (including any advance pricing agreement, closing agreement or other<br \/>\nagreement relating to taxes with any taxing authority).<\/p>\n<p>                  (e) None of the Company or any of its subsidiaries has taken<br \/>\nor agreed to take any action that would prevent the Merger from constituting a<br \/>\nreorganization qualifying under the provisions of Section 368(a) of the Code.<\/p>\n<p>                  (f) Except as disclosed in Section 2.13 of the Company<br \/>\nDisclosure Schedule, there are no employment, severance or termination<br \/>\nagreements, other compensation arrangements or Employee Benefit Plans currently<br \/>\nin effect which provide for the payment of any amount (whether in cash or<br \/>\nproperty or the vesting of property) as a result of any of the transactions<br \/>\ncontemplated by this Agreement to any employee, officer or director of the<br \/>\nCompany or any of its affiliates who is a &#8220;disqualified individual&#8221; (as such<br \/>\nterm is defined in Section 280G(c) of the Code), that would be characterized as<br \/>\nan &#8220;excess parachute payment&#8221; (as such term is defined in Section 280G(b)(1) of<br \/>\nthe Code).<\/p>\n<p>                  (g) Except as disclosed in Section 2.13 of the Company<br \/>\nDisclosure Schedule, no Federal, state, local or foreign audits or other<br \/>\nadministrative proceedings or court proceedings are presently pending with<br \/>\nregard to any Federal income or material state, local or foreign taxes or tax<br \/>\nreturns of the Company or any of its subsidiaries and neither the Company nor<br \/>\nany of its subsidiaries has received a written notice of any pending audit or<br \/>\nproceeding with regard to any federal income or material state, local or foreign<br \/>\ntaxes or tax returns of the Company or any of its subsidiaries.<\/p>\n<p>                  (h) Neither the Company nor any of its subsidiaries has agreed<br \/>\nto or is required to make any adjustment under Section 481(a) of the Code.<\/p>\n<p>                  (i) Neither the Company nor any of its subsidiaries has (i)<br \/>\nwith regard to any assets or property held or acquired by any of them, filed a<br \/>\nconsent to the application of Section 341(f) of the Code or agreed to have<br \/>\nSection 341(f)(2) of the Code apply to any disposition of a subsection (f) asset<br \/>\n(as such term is defined in Section 341(f)(4) of the Code) owned by the Company<br \/>\nor any of its subsidiaries or (ii) received, or filed any requests for, rulings<br \/>\nor determinations in respect of any taxes within the last five years.<\/p>\n<p>                  (j) No property owned by the Company or any of its<br \/>\nsubsidiaries (i) is property required to be treated as being owned by another<br \/>\nPerson pursuant to the provisions of Section 168(f)(8) of the Internal Revenue<br \/>\nCode of 1954, as amended and in effect immediately prior to the enactment of the<br \/>\nTax Reform Act of 1986; (ii) constitutes &#8220;tax exempt use property&#8221; within the<br \/>\nmeaning of Section 168(h)(1) of the Code; or (iii) is &#8220;tax exempt bond financed<br \/>\nproperty&#8221; within the meaning of Section 168(g) of the Code.<\/p>\n<p>                  (k) The Company and each of its subsidiaries are not<br \/>\ncurrently, have not been within the last five years, and do not anticipate<br \/>\nbecoming a &#8220;United States real property holding company&#8221; within the meaning of<br \/>\nSection 897(c) of the Code.<\/p>\n<p>                  (l) No subsidiary of the Company owns any Shares.<\/p>\n<p>                  SECTION 2.14. Intangible Property. To the Company&#8217;s knowledge,<br \/>\nthe Company and its subsidiaries own or possess adequate licenses or other valid<br \/>\nrights to use all patents, patent rights, trademarks, trademark rights, trade<br \/>\nnames, trade name rights, copyrights, service marks, trade secrets, applications<br \/>\nfor trademarks and for service marks, know-how and other proprietary rights and<br \/>\ninformation used or held for use in connection with the business of the Company<br \/>\nand its subsidiaries as currently conducted, except for failures to own or<br \/>\npossess adequate licenses or other valid rights to use any of the foregoing<br \/>\nwhich would not have a Company Material Adverse Effect, and, except as set forth<br \/>\nin the Company SEC Reports or Section 2.14 of the Company Disclosure Schedule,<br \/>\nto the knowledge of the Company there are no pending assertions or claims<br \/>\nchallenging the validity of any of the foregoing which would have a Company<br \/>\nMaterial Adverse Effect. Except as disclosed in Section 2.14 of the Company<br \/>\nDisclosure Schedule, to the Company&#8217;s knowledge, there are no current claims or<br \/>\nnotices that the manufacture and sale of the Company&#8217;s products infringes the<br \/>\npatents of any third party.<\/p>\n<p>                  SECTION 2.15. Opinion of Financial Advisor. Goldman, Sachs &amp; Co. (the &#8220;Financial Advisor&#8221;) has delivered to the Company Board its opinion to<br \/>\nthe effect that, as of the date of such opinion, the Exchange Ratio is fair to<br \/>\nthe holders of Shares, and such opinion has not been withdrawn.<\/p>\n<p>                  SECTION 2.16. Brokers. No broker, finder or investment banker<br \/>\n(other than the Financial Advisor, a true and correct copy of whose engagement<br \/>\nagreement has been provided to Parent) is entitled to any brokerage, finder&#8217;s or<br \/>\nother fee or commission or expense reimbursement in connection with the<br \/>\ntransactions contemplated by this Agreement based upon arrangements made by and<br \/>\non behalf of the Company or any of its affiliates.<\/p>\n<p>                  SECTION 2.17. Accounting Matters. Neither the Company nor, to<br \/>\nthe best of its knowledge, any of its affiliates or stockholders (including the<br \/>\nCompany Affiliates), has taken or agreed to take any action that would prevent<br \/>\nParent from accounting for the business combination to be effected by the Merger<br \/>\nas a &#8220;pooling-of-interests.&#8221; The Company has not failed to bring to the<br \/>\nattention of Parent any actions, or agreements or understandings, whether<br \/>\nwritten or oral, to act that would be reasonably likely to prevent Parent from<br \/>\naccounting for the Merger as a &#8220;pooling-of-interests.&#8221;<\/p>\n<p>                  SECTION 2.18. Material Contracts.<\/p>\n<p>                  (a) The Company has filed as an exhibit to an Annual Report on<br \/>\nForm 10-K or another document filed pursuant to the Securities Act or the<br \/>\nExchange Act, or has delivered or otherwise made available to Parent true,<br \/>\ncorrect and complete copies of all contracts and agreements to which the Company<br \/>\nor any of its subsidiaries is a party that are required to be filed in an<br \/>\nexhibit to an Annual Report on Form 10-K filed by the Company with the SEC as of<br \/>\nthe date of this Agreement (the &#8220;Contracts&#8221;). The Contracts include any<br \/>\nseverance or other agreement with any employee or consultant pursuant to which<br \/>\nsuch person would be entitled to receive any additional compensation or an<br \/>\naccelerated payment of compensation as a result of the consummation of the<br \/>\ntransactions contemplated hereby.<\/p>\n<p>                  (b) Each of the Contracts is valid and enforceable in<br \/>\naccordance with its terms, and there is no default under any Contract so listed<br \/>\neither by the Company or, to the knowledge of the Company, by any other party<br \/>\nthereto, and no event has occurred that with the lapse of time or the giving of<br \/>\nnotice or both would constitute a default thereunder by the Company or, to the<br \/>\nknowledge of the Company, any other party, in any such case in which such<br \/>\ndefault or event would have a Company Material Adverse Effect.<\/p>\n<p>                  (c) No party to any such Contract has given notice to the<br \/>\nCompany of or made a claim against the Company with respect to any breach or<br \/>\ndefault thereunder, in any such case in which such breach or default would have<br \/>\na Company Material Adverse Effect.<\/p>\n<p>                  SECTION 2.19. Products. Except as disclosed in the Company SEC<br \/>\nReports:<\/p>\n<p>                  (a) Each of the products currently being produced or sold by<br \/>\nthe Company and its subsidiaries (i) is in compliance in all material respects<br \/>\nwith all applicable U.S. federal, state and local laws and regulations and (ii)<br \/>\nconforms in all material respects to any promises or affirmations of fact made<br \/>\non the container or label for such product or in connection with its sale;<\/p>\n<p>                  (b) To the knowledge of the Company, no facts exist which<br \/>\nwould reasonably be expected to furnish a substantial basis for the recall,<br \/>\nwithdrawal or suspension by the Company or any of its subsidiaries of any such<br \/>\nproduct as a result of, or in order to comply with, any U.S. federal, state or<br \/>\nlocal law, regulation or rule or order of any Governmental Entity, except for<br \/>\nsuch recalls, withdrawals or suspensions as would not have a Company Material<br \/>\nAdverse Effect;<\/p>\n<p>                  (c) Section 2.19 of the Company Disclosure Schedule sets forth<br \/>\na list of all licenses and approvals granted by or pending with any Governmental<br \/>\nEntity in any country to market any product of the Company and its subsidiaries<br \/>\n(the &#8220;Company Product Registrations&#8221;). All products sold under the Company<br \/>\nProduct Registrations are manufactured and marketed in all material respects in<br \/>\naccordance with the specifications and standards contained in the Company<br \/>\nProduct Registrations. The Company and its subsidiaries have the sole rights<br \/>\nunder the Company Product Registrations and such registrations are in full force<br \/>\nand effect; and<\/p>\n<p>                  (d) Except as disclosed in Section 2.19 of the Company<br \/>\nDisclosure Schedule, since January 1, 1993, there have been no statements,<br \/>\ncitations, warning letters, FDA Forms 483, or decisions by any Governmental<br \/>\nEntity that any product produced, manufactured, marketed or distributed at any<br \/>\ntime by the Company or any of its subsidiaries is defective or fails to meet any<br \/>\napplicable standards promulgated by any such Governmental Entity. Except as<br \/>\ndisclosed in Section 2.19 of the Company Disclosure Schedule, there is no<br \/>\nproceeding by the FDA or any other Governmental Entity, including, but not<br \/>\nlimited to, a grand jury investigation, a 405 hearing or a civil penalty<br \/>\nproceeding, pending, or to the Company&#8217;s knowledge threatened, against the<br \/>\nCompany or any of its subsidiaries, and no such proceedings have been brought at<br \/>\nany time in the past relating to the safety or efficacy of the products of the<br \/>\nCompany and its subsidiaries and, to the Company&#8217;s knowledge, there is no basis<br \/>\nfor such a proceeding.<\/p>\n<p>                  SECTION 2.20. Amendment to Rights Agreement. The Company Board<br \/>\nhas taken all necessary action to amend the Rights Agreement, dated as of August<br \/>\n16, 1994, as amended, between the Company and Chemical Trust Company of<br \/>\nCalifornia, as Rights Agent (the &#8220;Rights Agreement&#8221;) so that none of the<br \/>\nexecution or delivery of this Agreement, the exchange of Parent Common Stock for<br \/>\nthe Shares in accordance with Article I, or any other transaction contemplated<br \/>\nhereby will cause (i) the rights (the &#8220;Rights&#8221;) issued pursuant to the Rights<br \/>\nAgreement to become exercisable under the Rights Agreement, (ii) Parent or<br \/>\nAcquisition to be deemed an &#8220;Acquiring Person&#8221; (as defined in the Rights<br \/>\nAgreement), or (iii) the &#8220;Shares Acquisition Date&#8221; (as defined in the Rights<br \/>\nAgreement) to occur upon any such event. The &#8220;Expiration Date&#8221; (as defined in<br \/>\nthe Rights Agreement) of the Rights shall occur immediately prior to the<br \/>\nEffective Time.<\/p>\n<p>                                    ARTICLE 3<\/p>\n<p>                         REPRESENTATIONS AND WARRANTIES<br \/>\n                            OF PARENT AND ACQUISITION<\/p>\n<p>                  Parent and Acquisition hereby represent and warrant to the<br \/>\nCompany as follows:<\/p>\n<p>                  SECTION 3.1. Organization.<\/p>\n<p>                  (a) Each of Parent and its subsidiaries is a corporation duly<br \/>\norganized, validly existing and in good standing under the laws of the<br \/>\njurisdiction of its incorporation and has all requisite corporate power and<br \/>\nauthority to own, lease and operate its properties and to carry on its<br \/>\nbusinesses as now being conducted, except where the failure to be so organized,<br \/>\nexisting and in good standing or to have such power and authority would not have<br \/>\na Parent Material Adverse Effect (as defined below). When used in connection<br \/>\nwith Parent or Acquisition, the term &#8220;Parent Material Adverse Effect&#8221; means any<br \/>\nchange or effect that is (i) materially adverse to the properties, business,<br \/>\nresults of operations or financial condition of Parent and its subsidiaries,<br \/>\ntaken as a whole, other than any change or effect arising out of general<br \/>\neconomic conditions unrelated to any businesses in which Parent and its<br \/>\nsubsidiaries are engaged or (ii) that would impair the ability of Parent and\/or<br \/>\nAcquisition to consummate the transactions contemplated hereby. The parties<br \/>\nacknowledge and agree that a decrease in the market value of the Parent Common<br \/>\nStock will not, in and of itself, constitute a Parent Material Adverse Effect.<\/p>\n<p>                  (b) Except as set forth in Section 3.1(b) of the Disclosure<br \/>\nSchedule previously delivered by Parent to the Company (the &#8220;Parent Disclosure<br \/>\nSchedule&#8221;), Parent has no subsidiaries and does not own, directly or indirectly,<br \/>\nbeneficially or of record, any shares of capital stock or other security of any<br \/>\nother entity or any other investment in any other entity.<\/p>\n<p>                  (c) Each of Parent and its subsidiaries is duly qualified or<br \/>\nlicensed and in good standing to do business in each jurisdiction in which the<br \/>\nproperty owned, leased or operated by it or the nature of the business conducted<br \/>\nby it makes such qualification or licensing necessary, except in such<br \/>\njurisdictions where the failure to be so duly qualified or licensed and in good<br \/>\nstanding would not have a Parent Material Adverse Effect.<\/p>\n<p>                  (d) Parent has heretofore delivered to the Company accurate<br \/>\nand complete copies of the articles of incorporation and by-laws, as currently<br \/>\nin effect, of Parent.<\/p>\n<p>                  SECTION 3.2. Capitalization of Parent and its Subsidiaries.<\/p>\n<p>                  (a) The authorized capital stock of Parent consists of (i)<br \/>\n250,000,000 shares of Parent Common Stock, of which, as of September 30, 1996,<br \/>\n80,976,337 shares of Parent Common Stock were issued and outstanding, and (ii)<br \/>\n25,000,000 shares of preferred stock, $.01 par value per share, of which, as of<br \/>\nthe date hereof, none are issued and outstanding. All of the shares of Parent<br \/>\nCommon Stock have been validly issued, and are fully paid, nonassessable and<br \/>\nfree of preemptive rights. As of September 30, 1996, 5,155,986 shares of Parent<br \/>\nCommon Stock were reserved for issuance and issuable upon or otherwise<br \/>\ndeliverable in connection with the exercise of outstanding options and 494,442<br \/>\nshares of Parent Common Stock were reserved for issuance in connection with<br \/>\nParent&#8217;s employee stock purchase savings plan. Except as set forth in Section<br \/>\n3.2 of the Parent Disclosure Schedule since September 30, 1996, no shares of<br \/>\nParent&#8217;s capital stock have been issued other than pursuant to stock options<br \/>\nalready in existence on September 30, 1996, and no stock options have been<br \/>\ngranted. Except as set forth above or as described in Section 3.2 of the Parent<br \/>\nDisclosure Schedule, as of the date hereof, there are outstanding (i) no shares<br \/>\nof capital stock or other voting securities of Parent, (ii) no securities of<br \/>\nParent or its subsidiaries convertible into or exchangeable for shares of<br \/>\ncapital stock or voting securities of Parent, (iii) no options or other rights<br \/>\nto acquire from Parent or its subsidiaries, and no obligations of Parent or its<br \/>\nsubsidiaries to issue, any capital stock, voting securities or securities<br \/>\nconvertible into or exchangeable for capital stock or voting securities of<br \/>\nParent, and (iv) no equity equivalents, interests in the ownership or earnings<br \/>\nof Parent or its subsidiaries or other similar rights (including stock<br \/>\nappreciation rights) (collectively, &#8220;Parent Securities&#8221;). There are no<br \/>\noutstanding obligations of Parent or any of its subsidiaries to repurchase,<br \/>\nredeem or otherwise acquire any Parent Securities. Except as set forth in<br \/>\nSection 3.2 of the Parent Disclosure Schedule, there are no stockholder<br \/>\nagreements, voting trusts or other agreements or understandings to which Parent<br \/>\nis a party or to which it is bound relating to the voting of any shares of<br \/>\ncapital stock of Parent.<\/p>\n<p>                  (b) All of the outstanding capital stock of Parent&#8217;s<br \/>\nsubsidiaries (including Acquisition) is owned by Parent, directly or indirectly,<br \/>\nfree and clear of any Lien or any other limitation or restriction (including any<br \/>\nrestriction on the right to vote or sell the same, except as may be provided as<br \/>\na matter of law). There are no securities of Parent or its subsidiaries<br \/>\nconvertible into or exchangeable for, no options or other rights to acquire from<br \/>\nParent or its subsidiaries, and no other contract, understanding, arrangement or<br \/>\nobligation (whether or not contingent) providing for the issuance or sale,<br \/>\ndirectly or indirectly, of any capital stock or other ownership interests in, or<br \/>\nany other securities of, any subsidiary of Parent. There are no outstanding<br \/>\ncontractual obligations of Parent or its subsidiaries to repurchase, redeem or<br \/>\notherwise acquire any outstanding shares of capital stock or other ownership<br \/>\ninterests in any subsidiary of Parent.<\/p>\n<p>                  SECTION 3.3. Authority Relative to this Agreement. Each of<br \/>\nParent and Acquisition has all necessary corporate power and authority to<br \/>\nexecute and deliver this Agreement and to consummate the transactions<br \/>\ncontemplated hereby. The execution and delivery of this Agreement and the<br \/>\nconsummation of the transactions contemplated hereby have been duly and validly<br \/>\nauthorized by the boards of directors of Parent and Acquisition and by Parent as<br \/>\nthe sole stockholder of Acquisition, and no other corporate proceedings on the<br \/>\npart of Parent or Acquisition are necessary to authorize this Agreement or to<br \/>\nconsummate the transactions contemplated hereby. This Agreement has been duly<br \/>\nand validly executed and delivered by each of Parent and Acquisition and<br \/>\nconstitutes a valid, legal and binding agreement of each of Parent and<br \/>\nAcquisition, enforceable against each of Parent and Acquisition in accordance<br \/>\nwith its terms, subject to the Bankruptcy and Equity Exception.<\/p>\n<p>                  SECTION 3.4. SEC Reports; Financial Statements.<\/p>\n<p>                  (a) Parent has filed all required forms, reports and documents<br \/>\nwith the SEC since January 1, 1995, each of which has complied in all material<br \/>\nrespects with all applicable requirements of the Securities Act and the Exchange<br \/>\nAct, each as in effect on the dates such forms, reports and documents were<br \/>\nfiled. Parent has heretofore delivered to the Company, in the form filed with<br \/>\nthe SEC (including any amendments thereto), (i) its Annual Reports on Form 10-K<br \/>\nfor the fiscal year ended December 31, 1995, (ii) all definitive proxy<br \/>\nstatements relating to Parent&#8217;s meetings of stockholders (whether annual or<br \/>\nspecial) held since January 1, 1996 and (iii) all other reports or registration<br \/>\nstatements filed by Parent with the SEC since January 1, 1995 (the &#8220;Parent SEC<br \/>\nReports&#8221;). As of their respective dates, none of such Parent SEC Reports<br \/>\ncontained any untrue statement of a material fact or omitted to state a material<br \/>\nfact required to be stated or incorporated by reference therein or necessary in<br \/>\norder to make the statements therein, in light of the circumstances under which<br \/>\nthey were made, not misleading. The consolidated financial statements of Parent<br \/>\nincluded in the Parent SEC Reports complied as to form in all material respects<br \/>\nwith applicable accounting requirements and the published rules and regulations<br \/>\nof the SEC with respect thereto and fairly present, in conformity with GAAP<br \/>\napplied on a consistent basis (except as may be indicated in the notes thereto),<br \/>\nthe consolidated financial position of Parent and its consolidated subsidiaries<br \/>\nas of the dates thereof and their consolidated results of operations and changes<br \/>\nin financial position for the periods then ended (subject, in the case of the<br \/>\nunaudited interim financial statements, to normal year-end adjustments). Since<br \/>\nDecember 31, 1995, except as set forth in the Parent SEC Reports, there has not<br \/>\nbeen any change, or any application or request for any change, by Parent or any<br \/>\nof its subsidiaries in accounting principles, methods or policies for financial<br \/>\naccounting or tax purposes.<\/p>\n<p>                  (b) Parent has heretofore made available to the Company a<br \/>\ncomplete and correct copy of any material amendments or modifications, which<br \/>\nhave not yet been filed with the SEC, to agreements, documents or other<br \/>\ninstruments which previously had been filed by Parent with the SEC pursuant to<br \/>\nthe Exchange Act.<\/p>\n<p>                  SECTION 3.5. Information Supplied. None of the information<br \/>\nsupplied or to be supplied by Parent or Acquisition for inclusion or<br \/>\nincorporation by reference in (i) the S-4 will, at the time the S-4 is filed<br \/>\nwith the SEC and at the time it becomes effective under the Securities Act,<br \/>\ncontain any untrue statement of a material fact or omit to state any material<br \/>\nfact required to be stated therein or necessary to make the statements therein<br \/>\nnot misleading and (ii) the Proxy Statement will, at the date mailed to<br \/>\nstockholders and at the time of the meeting of stockholders of the Company to be<br \/>\nheld in connection with the Merger, contain any untrue statement of a material<br \/>\nfact or omit to state any material fact required to be stated therein or<br \/>\nnecessary in order to make the statements therein, in light of the circumstances<br \/>\nunder which they are made, not misleading. If at any time prior to the Effective<br \/>\nTime any event with respect to Parent, its officers and directors or any of its<br \/>\nsubsidiaries should occur which is required to be described in an amendment of,<br \/>\nor a supplement to, the S-4 or the Proxy Statement, Parent shall promptly so<br \/>\nadvise the Company and such event shall be so described, and such amendment or<br \/>\nsupplement (which the Company shall have a reasonable opportunity to review)<br \/>\nshall be promptly filed with the SEC. The S-4 will comply as to form in all<br \/>\nmaterial respects with the provisions of the Securities Act and the rules and<br \/>\nregulations thereunder.<\/p>\n<p>                  SECTION 3.6. Consents and Approvals; No Violations. Except for<br \/>\nfilings, permits, authorizations, consents and approvals as may be required<br \/>\nunder, and other applicable requirements of, the Securities Act, the Exchange<br \/>\nAct, state securities or blue sky laws, the HSR Act, the filing and recordation<br \/>\nof the Certificate of Merger as required by the DGCL and as otherwise set forth<br \/>\nin Section 3.6 to the Parent Disclosure Schedule, no filing or registration with<br \/>\nor notice to, and no permit, authorization, consent or approval of, any<br \/>\nGovernmental Entity is necessary for the execution and delivery by Parent or<br \/>\nAcquisition of this Agreement or the consummation by Parent or Acquisition of<br \/>\nthe transactions contemplated hereby, except where the failure to obtain such<br \/>\npermits, authorizations, consents or approvals or to make such filings or give<br \/>\nsuch notice would not have a Parent Material Adverse Effect. Except as set forth<br \/>\nin Section 3.6 of the Parent Disclosure Schedule, neither the execution,<br \/>\ndelivery and performance of this Agreement by Parent or Acquisition nor the<br \/>\nconsummation by Parent or Acquisition of the transactions contemplated hereby<br \/>\nwill (i) conflict with or result in any breach of any provision of the<br \/>\nrespective articles of incorporation or bylaws (or similar governing documents)<br \/>\nof Parent or Acquisition or any of Parent&#8217;s subsidiaries, (ii) result in a<br \/>\nviolation or breach of, or constitute (with or without due notice or lapse of<br \/>\ntime or both) a default (or give rise to any right of termination, amendment,<br \/>\ncancellation or acceleration or Lien) under, any of the terms, conditions or<br \/>\nprovisions of any note, bond, mortgage, indenture, lease, license, contract,<br \/>\nagreement or other instrument or obligation to which Parent or Acquisition or<br \/>\nany of Parent&#8217;s subsidiaries is a party or by which any of them or any of their<br \/>\nrespective properties or assets may be bound or (iii) violate any order, writ,<br \/>\ninjunction, decree, law, statute, rule or regulation applicable to Parent or<br \/>\nAcquisition or any of Parent&#8217;s subsidiaries or any of their respective<br \/>\nproperties or assets, except in the case of (ii) or (iii) for violations,<br \/>\nbreaches or defaults which would not have a Parent Material Adverse Effect.<\/p>\n<p>                  SECTION 3.7. No Default. None of the Parent or its<br \/>\nsubsidiaries is in default or violation (and no event has occurred which with<br \/>\nnotice or the lapse of time or both would constitute a default or violation) of<br \/>\nany term, condition or provision of (i) its certificate or articles of<br \/>\nincorporation or bylaws (or similar governing documents), (ii) any note, bond,<br \/>\nmortgage, indenture, lease, license, contract, agreement or other instrument or<br \/>\nobligation to which Parent or any of its subsidiaries is now a party or by which<br \/>\nany of them or any of their respective properties or assets may be bound or<br \/>\n(iii) any order, writ, injunction, decree, law, statute, rule or regulation<br \/>\napplicable to Parent, its subsidiaries or any of their respective properties or<br \/>\nassets, except in the case of (ii) or (iii) for violations, breaches or defaults<br \/>\nthat would not have a Parent Material Adverse Effect.<\/p>\n<p>                  SECTION 3.8. No Undisclosed Liabilities; Absence of Changes.<br \/>\nExcept as and to the extent publicly disclosed by Parent in the Parent SEC<br \/>\nReports, as of June 30, 1996, none of Parent or its subsidiaries had any<br \/>\nliabilities or obligations of any nature, whether or not accrued, contingent or<br \/>\notherwise, and whether due or to become due or asserted or unasserted, which<br \/>\nwould be required by GAAP to be reflected in, reserved against or otherwise<br \/>\ndescribed in the consolidated balance sheet of Parent (including the notes<br \/>\nthereto) as of such date. Except as publicly disclosed by Parent in the Parent<br \/>\nSEC Reports and except for the execution by Parent, Acquisition and certain<br \/>\naffiliates of Parent of that certain Asset Purchase Agreement (United States),<br \/>\ndated as of September 24, 1996, among Acquisition, Telectronics Pacing Systems,<br \/>\nInc. and TPLC, Inc., the International Purchase Agreements referred to in such<br \/>\nAsset Purchase Agreement (United States) and the other agreements to be executed<br \/>\npursuant to such Asset Purchase Agreement (United States) and International<br \/>\nPurchase Agreements (collectively, the &#8220;Telectronics Agreements&#8221;), since the<br \/>\ndate of the end of the period covered by the latest Parent SEC Report, (i) the<br \/>\nbusiness of Parent and its subsidiaries has been carried on only in the ordinary<br \/>\nand usual course, and (ii) to the knowledge of Parent, none of Parent or its<br \/>\nsubsidiaries has incurred any liabilities of any nature, whether or not accrued,<br \/>\ncontingent or otherwise, which would have, and there have been no events,<br \/>\nchanges or effects with respect to Parent or its subsidiaries which would have,<br \/>\na Parent Material Adverse Effect. For purposes of this Agreement, &#8220;knowledge of<br \/>\nthe Parent&#8221; means the actual knowledge of any executive officer or member of the<br \/>\nBoard of Directors of the Parent as listed in Section 3.8 of the Parent<br \/>\nDisclosure Schedule.<\/p>\n<p>                  SECTION 3.9. Litigation. Except as publicly disclosed by<br \/>\nParent in the Company SEC Reports or disclosed in Section 3.9 of the Parent<br \/>\nDisclosure Schedule, there is no suit, claim, action, proceeding or<br \/>\ninvestigation pending or, to the knowledge of Parent, threatened against Parent<br \/>\nor any of its subsidiaries or any of their respective properties or assets which<br \/>\n(i) would have, individually or in the aggregate, a Parent Material Adverse<br \/>\nEffect or (ii) as of the date hereof, questions the validity of this Agreement<br \/>\nor any action to be taken by Parent in connection with the consummation of the<br \/>\ntransactions contemplated hereby or could otherwise prevent or delay the<br \/>\nconsummation of the transactions contemplated by this Agreement. Except as<br \/>\npublicly disclosed by Parent, none of Parent or its subsidiaries is subject to<br \/>\nany outstanding order, writ, injunction or decree which would have a Parent<br \/>\nMaterial Adverse Effect or would prevent or delay the consummation of the<br \/>\ntransactions contemplated hereby.<\/p>\n<p>                  SECTION 3.10. Compliance with Applicable Law. Except as<br \/>\npublicly disclosed by Parent in the Parent SEC Reports, Parent and its<br \/>\nsubsidiaries hold all permits, licenses, variances, exemptions, orders and<br \/>\napprovals of all Governmental Entities necessary for the conduct of their<br \/>\nrespective businesses as presently conducted (the &#8220;Parent Permits&#8221;), except for<br \/>\nfailures to hold such permits, licenses, variances, exemptions, orders and<br \/>\napprovals which would have a Parent Material Adverse Effect. Except as publicly<br \/>\ndisclosed by Parent in the Parent SEC Reports, Parent and its subsidiaries are<br \/>\nin compliance with the terms of the Parent Permits, except where the failure so<br \/>\nto comply would not have a Parent Material Adverse Effect. Except as publicly<br \/>\ndisclosed by Parent in the Parent SEC Reports, the businesses of Parent and its<br \/>\nsubsidiaries are not being conducted in violation of any law, ordinance or<br \/>\nregulation of any Governmental Entity, except for violations or possible<br \/>\nviolations which would not have a Parent Material Adverse Effect. Except as<br \/>\npublicly disclosed by Parent in the Parent SEC Reports, to the knowledge of<br \/>\nParent, no investigation or review by any Governmental Entity with respect to<br \/>\nParent or its subsidiaries is pending or threatened, nor, to the knowledge of<br \/>\nParent, has any Governmental Entity indicated an intention to conduct the same,<br \/>\nother than, in each case, those which would not have a Parent Material Adverse<br \/>\nEffect.<\/p>\n<p>                  SECTION 3.11. Tax Matters. Neither Parent nor any of its<br \/>\naffiliates has taken or agreed to take any action that would prevent the Merger<br \/>\nfrom constituting a reorganization qualifying under the provisions of Section<br \/>\n368(a) of the Code.<\/p>\n<p>                  SECTION 3.12. Products. Except as disclosed in the Parent SEC<br \/>\nReports and except for the products to be acquired pursuant to the Telectronics<br \/>\nAgreements, as to which no representation or warranty is being made hereunder:<\/p>\n<p>                  (a) Each of the products currently being produced or sold by<br \/>\nParent and its subsidiaries (i) is in compliance in all material respects with<br \/>\nall applicable U.S. federal, state and local laws and regulations and (ii)<br \/>\nconforms in all material respects to any promises or affirmations of fact made<br \/>\non the container or label for such product or in connection with its sale;<\/p>\n<p>                  (b) To the knowledge of Parent, no facts exist which would<br \/>\nreasonably be expected to furnish a substantial basis for the recall, withdrawal<br \/>\nor suspension by Parent or any of its subsidiaries of any such product as a<br \/>\nresult of, or in order to comply with, any U.S. federal, state or local law,<br \/>\nregulation or rule or order of any Governmental Entity, except for such recalls,<br \/>\nwithdrawals or suspensions as would not have a Parent Material Adverse Effect;<\/p>\n<p>                  (c) All products sold under all licenses and approvals granted<br \/>\nby or pending with any Governmental Entity in any country to market any product<br \/>\nof Parent and it subsidiaries (the &#8220;Parent Product Registrations&#8221;) are<br \/>\nmanufactured and marketed in all material respects in accordance with the<br \/>\nspecifications and standards contained in the Parent Product Registrations.<br \/>\nParent and its subsidiaries have the sole rights under the Parent Product<br \/>\nRegistrations in the United States and such registrations are in full force and<br \/>\neffect; and<\/p>\n<p>                  (d) As of the date hereof, there are no pending and<br \/>\nunsatisfied statements, citations, warning letters, FDA Forms 483, or decisions<br \/>\nby any United States Governmental Entity that any product produced,<br \/>\nmanufactured, marketed or distributed by Parent or any of its subsidiaries is<br \/>\ndefective or fails to meet any applicable standards promulgated by any such<br \/>\nUnited States Governmental Entity. There is no proceeding by the FDA or any<br \/>\nother United States Governmental Agency, including, but not limited to, a grand<br \/>\njury investigation, a 405 hearing or a civil penalty proceeding, pending, or to<br \/>\nParent&#8217;s knowledge threatened, against Parent or any of its subsidiaries,<br \/>\nrelating to the safety or efficacy of the products of Parent and its<br \/>\nsubsidiaries and, to Parent&#8217;s knowledge, there is no basis for such a<br \/>\nproceeding.<\/p>\n<p>                  SECTION 3.13. Intangible Property. To Parent&#8217;s knowledge,<br \/>\nParent and its subsidiaries own or possess adequate licenses or other valid<br \/>\nrights to use all patents, patent rights, trademarks, trademark rights, trade<br \/>\nnames, trade name rights, copyrights, service marks, trade secrets, applications<br \/>\nfor trademarks and for service marks, know-how and other proprietary rights and<br \/>\ninformation used or held for use in connection with the business of Parent and<br \/>\nits subsidiaries as currently conducted, except for failures to own or possess<br \/>\nadequate licenses or other valid rights to use any of the foregoing which would<br \/>\nnot have a Parent Material Adverse Effect, and, except as set forth in the<br \/>\nParent SEC Reports or Section 3.13 of the Parent Disclosure Schedule, to the<br \/>\nknowledge of Parent there are no pending assertions or claims challenging the<br \/>\nvalidity of any of the foregoing which would have a Parent Material Adverse<br \/>\nEffect. Except as disclosed in Section 3.13 of the Parent Disclosure Schedule,<br \/>\nto Parent&#8217;s knowledge, there are no pending claims or notices that the<br \/>\nmanufacture and sale of Parent&#8217;s products infringes the patents of any third<br \/>\nparty.<\/p>\n<p>                  SECTION 3.14. Brokers. No broker, finder or investment banker<br \/>\n(other than CS First Boston) is entitled to any brokerage, finder&#8217;s or other fee<br \/>\nor commission or expense reimbursement in connection with the transactions<br \/>\ncontemplated by this Agreement based upon arrangements made by and on behalf of<br \/>\nParent or Acquisition or any of their affiliates.<\/p>\n<p>                  SECTION 3.15. Accounting Matters. Neither Parent nor, to the<br \/>\nbest of its knowledge, any of its affiliates, has taken or agreed to take any<br \/>\naction that would prevent Parent from accounting for the business combination to<br \/>\nbe effected by the Merger as a &#8220;pooling-of-interests.&#8221; Parent has not failed to<br \/>\nbring to the attention of the Company any actions, or agreements or<br \/>\nunderstandings, whether written or oral, to act that would be reasonably likely<br \/>\nto prevent Parent from accounting for the Merger as a &#8220;pooling-of-interests.&#8221;<\/p>\n<p>                  SECTION 3.16. Telectronics Agreements. Parent has furnished to<br \/>\ncounsel to the Company true, complete and correct copies of all Telectronics<br \/>\nAgreements in effect as of the date of this Agreement and any written documents,<br \/>\ninstruments or other arrangements executed by the parties thereto in connection<br \/>\ntherewith.<\/p>\n<p>                  SECTION 3.17. Medtronic Agreement. The License Agreement,<br \/>\ndated August 26, 1992, between Medtronic Inc. and Siemens AG as assigned to<br \/>\nParent on August 23, 1994 is in full force and effect and will not by its terms<br \/>\nterminate by reason of the Merger.<\/p>\n<p>                                   ARTICLE 4<\/p>\n<p>                                    COVENANTS<\/p>\n<p>                  SECTION 4.1. Conduct of Business of the Company and Parent.<\/p>\n<p>                  (a) Except as contemplated by this Agreement or Section 4.1 of<br \/>\nthe Company Disclosure Schedule, during the period from the date hereof to the<br \/>\nEffective Time, the Company will, and will cause each of its subsidiaries to,<br \/>\nconduct its operations in the ordinary course of business consistent with past<br \/>\npractice and, to the extent consistent therewith, with no less diligence and<br \/>\neffort than would be applied in the absence of this Agreement, seek to preserve<br \/>\nintact its current business organizations, seek to keep available the service of<br \/>\nits current officers and employees and seek to preserve its relationships with<br \/>\ncustomers, suppliers and others having business dealings with it. Without<br \/>\nlimiting the generality of the foregoing, and except as otherwise expressly<br \/>\nprovided in this Agreement, prior to the Effective Time, neither the Company nor<br \/>\nany of its subsidiaries will, without the prior written consent of Parent, which<br \/>\nconsent shall not be unreasonably withheld:<\/p>\n<p>                  (i) amend its certificate of incorporation or bylaws (or other<br \/>\n         similar governing instrument);<\/p>\n<p>                  (ii) authorize for issuance, issue, sell, deliver or agree or<br \/>\n         commit to issue, sell or deliver (whether through the issuance or<br \/>\n         granting of options, warrants, commitments, subscriptions, rights to<br \/>\n         purchase or otherwise) any stock of any class or any other securities<br \/>\n         or equity equivalents (including, without limitation, any stock options<br \/>\n         or stock appreciation rights), except for the sale of up to 78,813<br \/>\n         shares of Company Common Stock to employees under the ESPP, the<br \/>\n         issuance of shares of Company Common Stock pursuant to the conversion<br \/>\n         of the Convertible Notes in accordance with the terms thereof and the<br \/>\n         issuance or sale of shares of Company Common Stock pursuant to<br \/>\n         outstanding options granted prior to the date hereof under the Company<br \/>\n         Plans (in each case, in the ordinary course of business and consistent<br \/>\n         with past practice);<\/p>\n<p>                  (iii) split, combine or reclassify any shares of its capital<br \/>\n         stock, declare, set aside or pay any dividend or other distribution<br \/>\n         (whether in cash, stock or property or any combination thereof) in<br \/>\n         respect of its capital stock, make any other actual, constructive or<br \/>\n         deemed distribution in respect of any shares of its capital stock or<br \/>\n         otherwise make any payments to stockholders in their capacity as such,<br \/>\n         or, except as set forth in Section 4.1(c) below, redeem or otherwise<br \/>\n         acquire any of its securities or any securities of any of its<br \/>\n         subsidiaries;<\/p>\n<p>                  (iv) adopt a plan of complete or partial liquidation,<br \/>\n         dissolution, merger, consolidation, restructuring, recapitalization or<br \/>\n         other reorganization of the Company or any of its subsidiaries (other<br \/>\n         than the Merger);<\/p>\n<p>                  (v) alter through merger, liquidation, reorganization,<br \/>\n         restructuring or in any other fashion the corporate structure or<br \/>\n         ownership of any subsidiary in a manner that would have a Company<br \/>\n         Material Adverse Effect;<\/p>\n<p>                  (vi) (A) incur or assume any long-term or short-term debt or<br \/>\n         issue any debt securities except for borrowings under existing lines of<br \/>\n         credit in the ordinary course of business and in amounts not material<br \/>\n         to the Company and its subsidiaries taken as a whole; (B) assume,<br \/>\n         guarantee, endorse or otherwise become liable or responsible (whether<br \/>\n         directly, contingently or otherwise) for the obligations of any other<br \/>\n         person except in the ordinary course of business consistent with past<br \/>\n         practice and in amounts not material to the Company and its<br \/>\n         subsidiaries, taken as a whole, and except for obligations of the<br \/>\n         wholly owned subsidiaries of the Company; (C) make any loans, advances<br \/>\n         or capital contributions to, or investments in, any other person (other<br \/>\n         than to the wholly owned subsidiaries of the Company or customary loans<br \/>\n         or advances to employees in the ordinary course of business consistent<br \/>\n         with past practice and in amounts not material to the maker of such<br \/>\n         loan or advance); (D) pledge or otherwise encumber shares of capital<br \/>\n         stock of the Company or its subsidiaries; or (E) mortgage or pledge any<br \/>\n         of its material assets, tangible or intangible, or create, grant or<br \/>\n         incur any material Lien thereupon;<\/p>\n<p>                  (vii) except as may be required by law or as contemplated by<br \/>\n         this Agreement, enter into, adopt or amend or terminate any bonus,<br \/>\n         profit sharing, compensation, severance, termination, stock option<br \/>\n         (except for normal grants to newly hired or current employees,<br \/>\n         consistent with past practice), stock appreciation right, restricted<br \/>\n         stock, performance unit, stock equivalent, stock purchase agreement,<br \/>\n         pension, retirement, deferred compensation, employment, severance or<br \/>\n         other employee benefit agreement, trust, plan, fund, award or other<br \/>\n         arrangement for the benefit or welfare of any director, officer or<br \/>\n         employee in any manner, or (except for normal increases in the ordinary<br \/>\n         course of business consistent with past practice that, in the<br \/>\n         aggregate, do not result in a material increase in benefits or<br \/>\n         compensation expense to the Company, and as required under existing<br \/>\n         agreements or in the ordinary course of business generally consistent<br \/>\n         with past practice) increase in any manner the compensation or fringe<br \/>\n         benefits of any director, officer or employee or pay any benefit not<br \/>\n         required by any plan and arrangement as in effect as of the date hereof<br \/>\n         (including, without limitation, the granting of stock appreciation<br \/>\n         rights or performance units);<\/p>\n<p>                  (viii) acquire, sell, lease or dispose of any assets outside<br \/>\n         the ordinary course of business or any assets which in the aggregate<br \/>\n         are material to the Company and its subsidiaries taken as a whole,<br \/>\n         enter into any commitment or transaction outside the ordinary course of<br \/>\n         business or grant any exclusive distribution rights;<\/p>\n<p>                  (ix) except as may be required as a result of a change in law<br \/>\n         or in generally accepted accounting principles, change any of the<br \/>\n         accounting principles or practices used by it;<\/p>\n<p>                  (x) revalue in any material respect any of its assets,<br \/>\n         including, without limitation, writing down the value of inventory or<br \/>\n         writing-off notes or accounts receivable other than in the ordinary<br \/>\n         course of business or as required by generally accepted accounting<br \/>\n         principles;<\/p>\n<p>                  (xi) (A) acquire (by merger, consolidation, or acquisition of<br \/>\n         stock or assets) any corporation, partnership or other business<br \/>\n         organization or division thereof or any equity interest therein; (B)<br \/>\n         enter into any contract or agreement, other than in the ordinary course<br \/>\n         of business or amend in any material respect any of the Contracts or<br \/>\n         the agreements referred to in Section 2.18; (C) authorize any new<br \/>\n         capital expenditure or expenditures which, individually, is in excess<br \/>\n         of $500,000 or, in the aggregate, are in excess of $5 million;<br \/>\n         PROVIDED, that none of the foregoing shall limit any capital<br \/>\n         expenditure already included in the Company&#8217;s fiscal 1996 or fiscal<br \/>\n         1997 capital expenditure budget provided to Parent prior to the date<br \/>\n         hereof; or (D) enter into or amend any contract, agreement, commitment<br \/>\n         or arrangement providing for the taking of any action that would be<br \/>\n         prohibited hereunder;<\/p>\n<p>                  (xii) make or revoke any tax election or settle or compromise<br \/>\n         any tax liability in a manner that involves the payment of a sum of<br \/>\n         money in excess of $100,000 or change (or make a request to any taxing<br \/>\n         authority to change) any material aspect of its method of accounting<br \/>\n         for tax purposes;<\/p>\n<p>                  (xiii) pay, discharge or satisfy any material claims,<br \/>\n         liabilities or obligations (absolute, accrued, asserted or unasserted,<br \/>\n         contingent or otherwise), other than the payment, discharge or<br \/>\n         satisfaction in the ordinary course of business of liabilities<br \/>\n         reflected or reserved against in, or contemplated by, the consolidated<br \/>\n         financial statements (or the notes thereto) of the Company and its<br \/>\n         subsidiaries or incurred in the ordinary course of business consistent<br \/>\n         with past practice;<\/p>\n<p>                  (xiv) settle or compromise any pending or threatened suit,<br \/>\n         action or claim relating to the transactions contemplated hereby in a<br \/>\n         manner that involves the payment of a sum of money in excess of<br \/>\n         $100,000 or that imposes material non-monetary obligations on the<br \/>\n         Company; or<\/p>\n<p>                  (xv) take, propose to take, or agree in writing or otherwise<br \/>\n         to take, any of the actions described above or any action which would<br \/>\n         make any of the representations or warranties of the Company contained<br \/>\n         in this Agreement untrue or incorrect in any material respect.<\/p>\n<p>                  (b) Except as otherwise expressly provided in this Agreement,<br \/>\nprior to the Effective Time, neither Parent nor any of its subsidiaries will,<br \/>\nwithout the prior written consent of the Company, which consent shall not be<br \/>\nunreasonably withheld:<\/p>\n<p>                  (i) amend its certificate of incorporation or bylaws (or other<br \/>\n         similar governing instrument);<\/p>\n<p>                  (ii) authorize for issuance, issue, sell, deliver or agree or<br \/>\n         commit to issue, sell or deliver (whether through the issuance or<br \/>\n         granting of warrants, commitments, subscriptions, rights to purchase or<br \/>\n         otherwise) any stock of any class or any other securities or equity<br \/>\n         equivalents, except for the sale of shares of Parent Common Stock to<br \/>\n         employees under the Parent&#8217;s employee stock purchase savings plan, the<br \/>\n         issuance of shares of Parent Common Stock pursuant to outstanding<br \/>\n         options granted prior to the date hereof under the Parent&#8217;s employee<br \/>\n         stock option plans and the grant of options after the date hereof (and<br \/>\n         the issuance of shares pursuant thereto) pursuant to such plans (in<br \/>\n         each case, in the ordinary course of business and consistent with past<br \/>\n         practice);<\/p>\n<p>                  (iii) split, combine or reclassify any shares of its capital<br \/>\n         stock, declare, set aside or pay any dividend or other distribution<br \/>\n         (whether in cash, stock or property or any combination thereof) in<br \/>\n         respect of its capital stock (other than in respect of periodic regular<br \/>\n         cash dividends), make any other actual, constructive or deemed<br \/>\n         distribution in respect of any shares of its capital stock or otherwise<br \/>\n         make any payments to stockholders in their capacity as such, or redeem<br \/>\n         or otherwise acquire any of its securities or any securities of any of<br \/>\n         its subsidiaries;<\/p>\n<p>                  (iv) adopt a plan of complete or partial liquidation,<br \/>\n         dissolution, merger, consolidation, restructuring, recapitalization or<br \/>\n         other reorganization of Parent or any of its subsidiaries (other than<br \/>\n         the Merger);<\/p>\n<p>                  (v) alter through merger, liquidation, reorganization,<br \/>\n         restructuring or in any other fashion the corporate structure or<br \/>\n         ownership of any subsidiary in a manner that would have a Parent<br \/>\n         Material Adverse Effect;<\/p>\n<p>                  (vi) except as may be required as a result of a change in law<br \/>\n         or in generally accepted accounting principles, change any of the<br \/>\n         accounting principles or practices used by it; or<\/p>\n<p>                  (vii) take, propose to take, or agree in writing or otherwise<br \/>\n         to take, any of the actions described above or any actions which would<br \/>\n         make any of the representations or warranties of the Company contained<br \/>\n         in this Agreement untrue or incorrect in any material respect.<\/p>\n<p>                  (c) Notwithstanding the provisions of Section 4.1(a) hereof,<br \/>\n         following the public announcement of the execution of this Agreement<br \/>\n         and prior to the Effective Time, the Company shall repurchase in open<br \/>\n         market transactions 200,000 shares of Company Common Stock outstanding<br \/>\n         on the date hereof.<\/p>\n<p>                  SECTION 4.2. Preparation of S-4 and the Proxy Statement. The<br \/>\nCompany will, as promptly as practicable, prepare and file with the SEC the<br \/>\nProxy Statement in connection with the vote of the stockholders of the Company<br \/>\nwith respect to the Merger. Parent will, as promptly as practicable, prepare,<br \/>\nfollowing receipt of notification from the SEC that it has no further comments<br \/>\non the Proxy Statement, and file with the SEC the S-4, containing a proxy<br \/>\nstatement\/prospectus and form of proxy, in connection with the registration<br \/>\nunder the Securities Act of the shares of Parent Common Stock issuable upon<br \/>\nconversion of the Shares and the other transactions contemplated hereby. Parent<br \/>\nand the Company will, and will cause their accountants and lawyers to, use all<br \/>\nreasonable best efforts to have or cause the S-4 declared effective as promptly<br \/>\nas practicable, including, without limitation, causing their accountants to<br \/>\ndeliver necessary or required instruments such as opinions, consents and<br \/>\ncertificates, and will take any other action required or necessary to be taken<br \/>\nunder federal or state securities laws or otherwise in connection with the<br \/>\nregistration process. The Company will use its reasonable best efforts to cause<br \/>\nthe Proxy Statement to be mailed to its stockholders at the earliest practicable<br \/>\ndate.<\/p>\n<p>                  SECTION 4.3. No Solicitation.<\/p>\n<p>                  (a) Until the earlier of the Effective Time or the termination<br \/>\nof this Agreement, the Company agrees that neither it nor any of its<br \/>\nsubsidiaries, nor any of the officers, directors or employees of it or its<br \/>\nsubsidiaries shall, and it shall direct and use its best efforts to cause its<br \/>\nand its subsidiaries&#8217; representatives and agents (including, without limitation,<br \/>\nany investment banker, attorney or accountant retained by the Company or any of<br \/>\nits subsidiaries), not to, directly or indirectly, initiate, solicit or<br \/>\nknowingly encourage (including by way of furnishing non-public information or<br \/>\nassistance), or take any other action knowingly to facilitate, any inquiries or<br \/>\nthe making of any proposal that constitutes, or may reasonably be expected to<br \/>\nlead to, an Acquisition Proposal (as defined below), or enter into or maintain<br \/>\nor continue discussions or negotiate with any person or entity in furtherance of<br \/>\nsuch inquiries or to obtain an Acquisition Proposal or agree to or endorse any<br \/>\nAcquisition Proposal; provided, however, that nothing in this Agreement shall<br \/>\nprohibit the Company Board from (i) complying with Rule 14e-2 promulgated under<br \/>\nthe Exchange Act with regard to an Acquisition Proposal or (ii) furnishing<br \/>\ninformation to, or entering into discussions or negotiations with, any person or<br \/>\nentity that makes an unsolicited Acquisition Proposal after the date of this<br \/>\nAgreement, if, in the case referred to in clause (ii) above, the Company Board,<br \/>\nafter consultation with and based upon the advice of independent legal counsel,<br \/>\ndetermines in good faith that such action is likely to be required for the<br \/>\nCompany Board to comply with its fiduciary duties to stockholders under<br \/>\napplicable law and, prior to taking such action, the Company receives from such<br \/>\nperson or entity an executed confidentiality agreement in reasonably customary<br \/>\nform. For purposes of this Agreement, &#8220;Acquisition Proposal&#8221; means an inquiry,<br \/>\noffer or proposal regarding any of the following (other than the transactions<br \/>\ncontemplated by this Agreement) involving the Company or any of its<br \/>\nsubsidiaries: (w) any merger, consolidation, share exchange, recapitalization,<br \/>\nbusiness combination or other similar transaction; (x) any sale, lease,<br \/>\nexchange, mortgage, pledge, transfer or other disposition of all or<br \/>\nsubstantially all the assets of the Company and its subsidiaries, taken as a<br \/>\nwhole, in a single transaction or series of related transactions; (y) any tender<br \/>\noffer or exchange offer for 20 percent or more of the outstanding shares of<br \/>\nCompany Common Stock or the filing of a registration statement under the<br \/>\nSecurities Act in connection therewith; or (z) any public announcement of a<br \/>\nproposal, plan or intention to do any of the foregoing or any agreement to<br \/>\nengage in any of the foregoing.<\/p>\n<p>                  (b) Except as set forth in this Section 4.3(b), the Company<br \/>\nBoard shall not (i) withdraw or modify, or propose to withdraw or modify, in a<br \/>\nmanner adverse to Parent, the approval or recommendation by the Company Board,<br \/>\n(ii) approve or recommend, or propose to approve or recommend, any Acquisition<br \/>\nProposal or (iii) cause the Company to enter into any agreement with respect to<br \/>\nany Acquisition Proposal. Notwithstanding the foregoing, if the Board of<br \/>\nDirectors of the Company, after consultation with and based upon the advice of<br \/>\nindependent legal counsel, determines in good faith that it is necessary to do<br \/>\nso in order to comply with its fiduciary duties to stockholders under applicable<br \/>\nlaw, the Company Board may approve or recommend a Superior Proposal (as defined<br \/>\nbelow) or cause the Company to enter into an agreement with respect to a<br \/>\nSuperior Proposal, but in each case only (i) after providing reasonable written<br \/>\nnotice to Parent (a &#8220;Notice of Superior Proposal&#8221;) advising Parent that the<br \/>\nCompany Board has received a Superior Proposal, specifying the material terms<br \/>\nand conditions of such Superior Proposal and identifying the person making such<br \/>\nSuperior Proposal and (ii) if Parent does not make within 48 hours of Parent&#8217;s<br \/>\nreceipt of the Notice of Superior Proposal, an offer which the Company Board,<br \/>\nafter consultation with its financial advisors, determines is superior to such<br \/>\nSuperior Proposal. For purposes of this Agreement, a &#8220;Superior Proposal&#8221; means<br \/>\nany bona fide Acquisition Proposal that the Company Board determines in its good<br \/>\nfaith judgment (based on the advice of a financial advisor of nationally<br \/>\nrecognized reputation) to be more favorable to the Company&#8217;s stockholders than<br \/>\nthe Merger.<\/p>\n<p>                  SECTION 4.4. Intentionally omitted.<\/p>\n<p>                  SECTION 4.5. Stockholder Meeting. The Company shall call a<br \/>\nmeeting of its stockholders to be held as promptly as practicable for the<br \/>\npurpose of voting upon this Agreement and related matters. The Company will,<br \/>\nthrough the Company Board recommend to its stockholders approval of such<br \/>\nmatters; PROVIDED, HOWEVER, that the Company Board may withdraw its<br \/>\nrecommendation if the Company Board by a majority vote determines in its good<br \/>\nfaith judgment, after consultation with and based upon the advice of independent<br \/>\nlegal counsel, that it is necessary to do so to comply with its fiduciary duties<br \/>\nto stockholders under applicable law.<\/p>\n<p>                  SECTION 4.6. Access to Information.<\/p>\n<p>                  (a) Between the date hereof and the Effective Time, upon<br \/>\nreasonable notice and except as may be otherwise required by applicable law,<br \/>\neach party (for these purposes, Parent and Acquisition shall be deemed to be one<br \/>\nparty) will give to the other party and the other party&#8217;s authorized<br \/>\nrepresentatives reasonable access during normal business hours to its employees,<br \/>\nplants, offices, warehouses and other facilities and to all of its books and<br \/>\nrecords, will permit the other party to make such inspections as the other party<br \/>\nmay reasonably require and will cause its officers and those of its subsidiaries<br \/>\nto furnish the other party with such financial and operating data and other<br \/>\ninformation with respect to its business, properties and personnel as the other<br \/>\nparty may from time to time reasonably request, provided that no investigation<br \/>\npursuant to this Section 4.6(a) shall affect or be deemed to modify any of the<br \/>\nrepresentations or warranties made herein and provided, further, that the<br \/>\nforegoing shall not require either party to permit any inspection, or to<br \/>\ndisclose any information, that in its reasonable judgment would result in the<br \/>\nviolation of any of its obligations to a third party with respect to<br \/>\nconfidentiality if it shall have used best efforts to obtain the consent of such<br \/>\nthird party to such inspection or disclosure.<\/p>\n<p>                  (b) Between the date hereof and the Effective Time, the<br \/>\nCompany shall furnish to Parent and Acquisition within five business days after<br \/>\nthe delivery thereof to management, such monthly financial statements and data<br \/>\nas are regularly prepared for distribution to Company management. At the<br \/>\nearliest time they are available, each party shall furnish to the other party<br \/>\nsuch quarterly and annual financial statements as are prepared for its SEC<br \/>\nfilings, which shall be in accordance with its books and records.<\/p>\n<p>                  (c) Parent will furnish to counsel to the Company true,<br \/>\ncomplete and correct copies of all Telectronics Agreements (and any written<br \/>\ndocuments, instruments or other arrangements executed by the parties thereto in<br \/>\nconnection therewith) executed following the date hereof and on or prior to the<br \/>\nEffective Time.<\/p>\n<p>                  (d) Each party will hold and will cause its consultants and<br \/>\nadvisors to hold in confidence all documents and information concerning the<br \/>\nother party furnished to it in connection with the transactions contemplated by<br \/>\nthis Agreement pursuant to the terms of the Confidentiality Agreements entered<br \/>\ninto between the Company and Parent dated August 30, 1996.<\/p>\n<p>                  SECTION 4.7. Additional Agreements; Best Efforts. Subject to<br \/>\nthe terms and conditions herein provided, each of the parties hereto agrees to<br \/>\nuse its best efforts to take, or cause to be taken, all action, and to do, or<br \/>\ncause to be done, all things necessary, proper or advisable under applicable<br \/>\nlaws and regulations to consummate and make effective the transactions<br \/>\ncontemplated by this Agreement and the Telectronics Agreements as soon as<br \/>\npracticable, including, without limitation, (i) cooperation in the preparation<br \/>\nand filing of the Proxy Statement and the S-4 and any amendments to any thereof;<br \/>\n(ii) the taking of all action necessary, proper or advisable to secure any<br \/>\nnecessary consents of all third parties and Governmental Entities; (iii)<br \/>\ncontesting and resisting any legal proceeding relating to the Merger or the<br \/>\nTelectronics Agreements and having vacated, lifted, reversed or overturned any<br \/>\ndecree, judgment or other order that restricts, prevents or prohibits the Merger<br \/>\nor any other transaction contemplated hereby or by the Telectronics Agreements;<br \/>\nand (iv) the execution of any additional instruments, including the Certificate<br \/>\nof Merger, necessary to consummate the transactions contemplated hereby. In case<br \/>\nat any time after the Effective Time any further action is necessary to carry<br \/>\nout the purposes of this Agreement, the proper officers and directors of each<br \/>\nparty hereto shall take all such necessary action. Notwithstanding the<br \/>\nprovisions of this Section 4.7, except for contractual arrangements in effect on<br \/>\nthe date hereof, neither party shall be required to pay any amounts of money to<br \/>\nthird parties to secure any consent or approval or to agree to any request or<br \/>\nrequirement of any Governmental Entity that would materially impair or diminish<br \/>\nthe benefits or ownership rights expected to be derived by Parent or the Company<br \/>\nfrom the transactions contemplated by this Agreement and the Telectronics<br \/>\nAgreements.<\/p>\n<p>                  SECTION 4.8. Antitrust Reviews. Each party hereto will use its<br \/>\nbest efforts (a) to file with the US Department of Justice and US Federal Trade<br \/>\nCommission, as soon as practicable after the date hereof, the Notification and<br \/>\nReport Form under the HSR Act and any supplemental information or material<br \/>\nrequested pursuant to the HSR Act, and (b) to comply as soon as practicable<br \/>\nafter the date hereof with any other laws of any country and the European Union<br \/>\nunder which any consent, authorization, registration, declaration or other<br \/>\naction with respect to the transactions contemplated herein may be required.<br \/>\nEach party hereto shall furnish to the other such information and assistance as<br \/>\nthe other may reasonably request in connection with any filing or other act<br \/>\nundertaken in compliance with the HSR Act or other such laws, and shall keep<br \/>\neach other timely apprised of the status of any communications with, and any<br \/>\ninquiries or requests for additional information from, any Governmental Entity<br \/>\nunder the HSR Act or other such laws.<\/p>\n<p>                  SECTION 4.9. Public Announcements. Each of Parent, Acquisition<br \/>\nand the Company will consult with one another before issuing any press release<br \/>\nor otherwise making any public statements with respect to the transactions<br \/>\ncontemplated by this Agreement, including, without limitation, the Merger, and<br \/>\nshall not issue any such press release or make any such public statement or any<br \/>\nfiling with any third party or Governmental Entity prior to such consultation.<\/p>\n<p>                  SECTION 4.10. Indemnification; Directors&#8217; and Officers&#8217;<br \/>\nInsurance.<\/p>\n<p>                  (a) Indemnification. From and after the Effective Time, Parent<br \/>\nshall, to the fullest extent permitted by applicable law, indemnify, defend and<br \/>\nhold harmless each person who is now, or has been at any time prior to the date<br \/>\nhereof, or who becomes prior to the Effective Time, a director, officer or<br \/>\nemployee of the Company or any subsidiary thereof (each an &#8220;Indemnified Party&#8221;<br \/>\nand, collectively, the &#8220;Indemnified Parties&#8221;) against all losses, expenses and<br \/>\ncosts (including reasonable attorneys&#8217; fees and expenses), claims, damages or<br \/>\nliabilities or, subject to the proviso of the next succeeding sentence, amounts<br \/>\npaid in settlement, arising out of actions or omissions occurring at or prior to<br \/>\nthe Effective Time and whether asserted or claimed prior to, at or after the<br \/>\nEffective Time that are in whole or in part (i) based on, or arising out of the<br \/>\nfact that such person is or was a director, officer or employee of the Company<br \/>\nor one or more of its subsidiaries or (ii) based on, arising out of or<br \/>\npertaining to the transactions contemplated by this Agreement. Parent hereby<br \/>\nagrees that any loss, expense, cost (including reasonable attorneys&#8217; fees and<br \/>\nexpenses), claims, damages or liability suffered by any director, officer or<br \/>\nemployee of the Company arising out of any claim initiated by Intermedics, Inc.,<br \/>\nPeter Dorflinger or any other officer or employee of Intermedics, Inc. shall be<br \/>\ndeemed to be a loss, expense, cost, claim, damage or liability arising out of<br \/>\nthe fact that such person is or was a director, officer or employee of the<br \/>\nCompany or one or more of its subsidiaries. In the event of any loss, expense,<br \/>\nclaim, damage or liability (whether or not arising before the Effective Time)<br \/>\ndescribed in the first sentence of this Section 4.10(a), (i) Parent shall pay<br \/>\nthe reasonable fees and expenses of counsel selected by the Indemnified Parties,<br \/>\nwhich counsel shall be reasonably satisfactory to Parent, promptly after<br \/>\nstatements therefor are received and otherwise advance to such Indemnified Party<br \/>\nupon request reimbursement of documented expenses reasonably incurred, in either<br \/>\ncase to the extent not prohibited by the DGCL and upon receipt of any<br \/>\naffirmation and undertaking required by the DGCL, (ii) Parent will cooperate in<br \/>\nthe defense of any such matter and (iii) any determination required to be made<br \/>\nwith respect to whether an Indemnified Party&#8217;s conduct complies with the<br \/>\nstandards set forth under the DGCL and Parent&#8217;s articles of incorporation or<br \/>\nbylaws shall be made by independent counsel mutually acceptable to Parent and<br \/>\nthe Indemnified Party; PROVIDED, HOWEVER, that Parent shall not be liable for<br \/>\nany settlement effected without its written consent (which consent shall not be<br \/>\nreasonably withheld). The Indemnified Parties as a group may retain only one law<br \/>\nfirm with respect to each related matter except to the extent there is, in the<br \/>\nopinion of counsel to an Indemnified Party, under applicable standards of<br \/>\nprofessional conduct, a conflict on any significant issue between positions of<br \/>\nany two or more Indemnified Parties.<\/p>\n<p>                  (b) Insurance. For a period of three years after the Effective<br \/>\nTime, Parent shall cause to be maintained in effect the policies of directors&#8217;<br \/>\nand officers&#8217; liability insurance maintained by the Company for the benefit of<br \/>\nthose persons who are covered by such policies at the Effective Time (or Parent<br \/>\nmay substitute therefor policies of at least the same coverage with respect to<br \/>\nmatters occurring prior to the Effective Time), to the extent that such<br \/>\nliability insurance can be maintained annually at a cost to Parent not greater<br \/>\nthan 150 percent of the premium for the current Company directors&#8217; and officers&#8217;<br \/>\nliability insurance; provided that if such insurance cannot be so maintained or<br \/>\nobtained at such costs, Parent shall maintain or obtain as much of such<br \/>\ninsurance as can be so maintained or obtained at a cost equal to 150 percent of<br \/>\nthe current annual premiums of the Company for such insurance.<\/p>\n<p>                  (c) Successors. In the event Parent or any of its successors<br \/>\nor assigns (i) consolidates with or merges into any other person and shall not<br \/>\nbe the continuing or surviving corporation or entity or such consolidation or<br \/>\nmerger or (ii) transfers all or substantially all of its properties and assets<br \/>\nto any person, then and in either such case, proper provision shall be made so<br \/>\nthat the successors and assigns of Parent shall assume the obligations set for<br \/>\nin this Section 4.10.<\/p>\n<p>                  (d) Survival of Indemnification. To the fullest extent<br \/>\npermitted by law, from and after the Effective Time, all rights to<br \/>\nindemnification now existing in favor of the employees, agents, directors or<br \/>\nofficers of the Company and its subsidiaries with respect to their activities as<br \/>\nsuch prior to the Effective Time, as provided in the Company&#8217;s certificate of<br \/>\nincorporation or bylaws, in effect on the date thereof or otherwise in effect on<br \/>\nthe date hereof, shall survive the Merger and shall continue in full force and<br \/>\neffect for a period of not less than six years from the Effective Time.<\/p>\n<p>                  (e) Benefit. The provisions of this Section 4.10 are intended<br \/>\nto be for the benefit of, and shall be enforceable by, each Indemnified Party,<br \/>\nhis or her heirs and his or her representatives.<\/p>\n<p>                  SECTION 4.11. Notification of Certain Matters. The Company<br \/>\nshall give prompt notice to Parent and Acquisition, and Parent and Acquisition<br \/>\nshall give prompt notice to the Company, of the status of matters relating to<br \/>\ncompletion of the transactions contemplated hereby, including (i) the occurrence<br \/>\nor nonoccurrence of any event the occurrence or nonoccurrence of which would be<br \/>\nlikely to cause any representation or warranty contained in this Agreement to be<br \/>\nuntrue or inaccurate in any material respect at or prior to the Effective Time,<br \/>\n(ii) any material failure of the Company, Parent or Acquisition, as the case may<br \/>\nbe, to comply with or satisfy any covenant, condition or agreement to be<br \/>\ncomplied with or satisfied by it hereunder, (iii) any notice of, or other<br \/>\ncommunication relating to, a default or event which, with notice or lapse of<br \/>\ntime or both, would become a default, received by it or any of its subsidiaries<br \/>\nsubsequent to the date of this Agreement and prior to the Effective Time, under<br \/>\nany contract or agreement material to the financial condition, properties,<br \/>\nbusinesses or results of operations of it and its subsidiaries taken as a whole<br \/>\nto which it or any of its subsidiaries is a party or is subject, (iv) any notice<br \/>\nor other communication from any third party or Governmental Entity with respect<br \/>\nto the Merger or the other transactions contemplated hereby or alleging that the<br \/>\nconsent of such third party or Governmental Entity is or may be required in<br \/>\nconnection with the Merger or the other transactions contemplated by this<br \/>\nAgreement, or (v) any material adverse change in their respective financial<br \/>\ncondition, properties, businesses or results of operations, taken as a whole,<br \/>\nother than changes resulting from general economic conditions; PROVIDED,<br \/>\nHOWEVER, that the delivery of any notice pursuant to this Section 4.11 shall not<br \/>\ncure such breach or non-compliance or limit or otherwise affect the remedies<br \/>\navailable hereunder to the party receiving such notice.<\/p>\n<p>                  SECTION 4.12. Pooling. The Company and Parent each agrees that<br \/>\nit will not take any action which could prevent the Merger from being accounted<br \/>\nfor as a &#8220;pooling-of-interests&#8221; for accounting purposes, and the Company will<br \/>\nbring to the attention of Parent, and Parent will bring to the attention of the<br \/>\nCompany, any actions, or agreements or understandings, whether written or oral,<br \/>\nthat could be reasonably likely to prevent Parent from accounting for the Merger<br \/>\nas a &#8220;pooling-of-interests.&#8221; The Company and Parent shall use their best efforts<br \/>\nto cause Ernst &amp; Young LLP (&#8220;E&amp;Y&#8221;) to deliver to Parent and the Company a<br \/>\nletter, addressed to the Company and Parent, stating that after appropriate<br \/>\nreview of this Agreement and based upon its familiarity with the Company and<br \/>\nParent, following the Merger the Company and Parent are entities that qualify as<br \/>\nparties to a pooling of interests transaction under Opinion 16 of the Accounting<br \/>\nPrinciples Board and applicable SEC rules and regulations. Each party will<br \/>\ninform all Company Affiliates (as hereinafter defined in Section 4.15) and other<br \/>\nrelevant affiliates and employees of the parties as to those actions that should<br \/>\nor should not be taken by such persons so that the Merger will be accounted for<br \/>\nas a &#8220;pooling-of-interests&#8221; and will use its best efforts to cause such<br \/>\naffiliates and persons employed by it to take or not take such actions as either<br \/>\nparty may be informed by any Governmental Entity are necessary to be taken or<br \/>\nnot to be taken so that the Merger will be accounted for as a<br \/>\n&#8220;pooling-of-interests.&#8221;<\/p>\n<p>                  SECTION 4.13. Tax-Free Reorganization Treatment. The Company,<br \/>\nParent and Acquisition shall execute and deliver to Sullivan &amp; Cromwell, counsel<br \/>\nto the Company, and Weil, Gotshal &amp; Manges LLP, counsel to Parent, certificates<br \/>\ncontaining customary representations, at such time or times as reasonably<br \/>\nrequested by such law firms in connection with their respective deliveries of<br \/>\nopinions with respect to the transactions contemplated hereby.<\/p>\n<p>                  SECTION 4.14. Employee Matters.<\/p>\n<p>                  (a) For the period commencing with the Effective Time and<br \/>\nending on June 30, 1998, Parent shall and shall cause its subsidiaries to<br \/>\nmaintain with respect to their employees who had been employed by the Company or<br \/>\nany of its subsidiaries (i) base salary or regular hourly wage rates for each<br \/>\nsuch employee at not less than the rate applicable immediately prior to the<br \/>\nMerger to such employee, and (ii) benefits under employee benefit plans (as<br \/>\ndefined for purposes of Section 3(3) of ERISA), other than employee benefits as<br \/>\nto which the employees&#8217; interests are based upon the Shares, which are<br \/>\nsubstantially comparable in the aggregate to such benefits provided by the<br \/>\nCompany and its subsidiaries immediately prior to the Merger. Thereafter, in<br \/>\nParent&#8217;s discretion, either (i) the provisions of the preceding sentence shall<br \/>\nbe complied with by Parent or (ii) employees of the Company and its subsidiaries<br \/>\nshall be treated no less favorably under the compensation and benefits programs<br \/>\nof Parent than other similarly situated employees of Parent and its<br \/>\nsubsidiaries.<\/p>\n<p>                  (b) Parent and its subsidiaries shall credit employees of the<br \/>\nCompany and its subsidiaries with their service prior to the Merger with the<br \/>\nCompany and its subsidiaries to the same extent such service was counted under<br \/>\nthe Company ERISA Plans for all purposes other than benefit accruals under the<br \/>\ndefined benefit pension plans of Parent and its subsidiaries.<\/p>\n<p>                  (c) Parent will, and will cause the Surviving Corporation to,<br \/>\nhonor the employment and severance agreements and all other obligations of the<br \/>\nSurviving Corporation listed on Section 4.14(c) of the Company Disclosure<br \/>\nSchedule. Nothing contained herein shall be construed as requiring Parent or the<br \/>\nSurviving Corporation to continue any specific plans or to continue the<br \/>\nemployment of any specific person.<\/p>\n<p>                  SECTION 4.15. Company Affiliates. Prior to the Effective Time,<br \/>\neach of the Company and Parent will deliver to the other a letter identifying<br \/>\nall persons who, at the time of the meeting of the Company&#8217;s stockholders<br \/>\nreferred to in Section 4.5, it believes are its &#8220;affiliates&#8221; for purposes of<br \/>\nRule 145 under the Securities Act and for the purposes of applicable<br \/>\ninterpretations regarding the pooling-of-interests method of accounting (the<br \/>\npersons identified in the Company&#8217;s letter are each hereinafter referred to as a<br \/>\n&#8220;Company Affiliate&#8221; and the persons identified in Parent&#8217;s letter are each<br \/>\nhereinafter referred to as a &#8220;Parent Affiliate&#8221;). The Company shall use its best<br \/>\nefforts to obtain a written agreement on or prior to the Effective Time from<br \/>\neach person who is identified as a Company Affiliate providing that (i) such<br \/>\nCompany Affiliate will not sell, pledge, transfer or otherwise dispose of any<br \/>\nshares of Parent Common Stock issued to such Company Affiliate pursuant to the<br \/>\nMerger, except in compliance with Rule 145 promulgated under the Securities Act<br \/>\nor an exemption from the registration requirements of the Securities Act. Each<br \/>\nof the Company and Parent shall use its best efforts to obtain a written<br \/>\nagreement on or prior to the Effective Time from each Company Affiliate and<br \/>\nParent Affiliate, respectively, providing that (ii) on or prior to the earlier<br \/>\nof (x) the mailing of the Proxy Statement or (y) the thirtieth day prior to the<br \/>\nEffective Time such person will not thereafter sell or in any other way reduce<br \/>\nsuch person&#8217;s risk relative to any shares of Parent Common Stock (within the<br \/>\nmeaning of the SEC&#8217;s Financial Reporting Release No. 1, &#8220;Codification of<br \/>\nFinancing Reporting Policies,&#8221; ss. 201.01 47 F.R. 21028 (April 15, 1982)), until<br \/>\nsuch time as financial results (including combined sales and net income)<br \/>\ncovering at least 30 days of post-merger operations have been published, except<br \/>\nas permitted by Staff Accounting Bulletin No. 76 issued by the SEC.<\/p>\n<p>                  SECTION 4.16. SEC Filings. Each of Parent and the Company<br \/>\nshall promptly provide the other party (or its counsel) with copies of all<br \/>\nfilings made by the other party or any of its subsidiaries with the SEC or any<br \/>\nother state or federal Governmental Entity in connection with this Agreement and<br \/>\nthe transactions contemplated hereby.<\/p>\n<p>                  SECTION 4.17. Guarantee of Performance. Parent hereby<br \/>\nguarantees the performance by Acquisition of its obligations under this<br \/>\nAgreement.<\/p>\n<p>                                    ARTICLE 5<\/p>\n<p>                    CONDITIONS TO CONSUMMATION OF THE MERGER<\/p>\n<p>                  SECTION 5.1. Conditions to Each Party&#8217;s Obligations to Effect<br \/>\nthe Merger. The respective obligations of each party hereto to effect the Merger<br \/>\nare subject to the satisfaction at or prior to the Effective Time of the<br \/>\nfollowing conditions:<\/p>\n<p>                  (a) this Agreement shall have been approved and adopted by the<br \/>\nrequisite vote of the stockholders of the Company;<\/p>\n<p>                  (b) no statute, rule, regulation, executive order, decree,<br \/>\nruling or injunction shall have been enacted, entered, promulgated or enforced<br \/>\nby any court or other Governmental Entity and continued in effect which<br \/>\nprohibits, restrains, enjoins or restricts the consummation of the Merger;<\/p>\n<p>                  (c) any waiting period applicable to the Merger under the HSR<br \/>\nAct shall have terminated or expired, and any other governmental or regulatory<br \/>\nnotices or approvals required with respect to the transactions contemplated<br \/>\nhereby shall have been either filed or received;<\/p>\n<p>                  (d) the S-4 shall have become effective under the Securities<br \/>\nAct and shall not be the subject of any stop order or proceedings seeking a stop<br \/>\norder, and Parent shall have received all state securities laws or &#8220;blue sky&#8221;<br \/>\npermits and authorizations necessary to issue shares of Parent Common Stock in<br \/>\nexchange for the Shares in the Merger;<\/p>\n<p>                  (e) the Company and Parent each shall have received from E&amp;Y a<br \/>\nletter stating that after appropriate review of this Agreement and based upon<br \/>\nits familiarity with the Company and Parent, following the Merger the Company<br \/>\nand Parent are entities that qualify as parties to a pooling of interests<br \/>\ntransaction under Opinion 16 of the Accounting Principles Board and applicable<br \/>\nSEC rules and regulations and such letter shall not have been withdrawn or<br \/>\nmodified in any material respect;<\/p>\n<p>                  (f) [intentionally omitted]; and<\/p>\n<p>                  (g) the closing contemplated by the Asset Purchase Agreement<br \/>\n(United States), dated as of September 24, 1996, by and among Acquisition,<br \/>\nTelectronics Pacing Systems, Inc. and TPLC, Inc. shall have occurred.<\/p>\n<p>                  SECTION 5.2. Conditions to the Obligations of the Company. The<br \/>\nobligation of the Company to effect the Merger is subject to the satisfaction at<br \/>\nor prior to the Effective Time of the following conditions:<\/p>\n<p>                  (a) the representations and warranties of Parent and<br \/>\nAcquisition contained in this Agreement or in any other document delivered<br \/>\npursuant hereto shall be true and correct in all material respects at and as of<br \/>\nthe Effective Time with the same effect as if made at and as of the Effective<br \/>\nTime (except for the representation and warranty made in the first sentence of<br \/>\nSection 3.12(d), which is being made only as of the date of this Agreement), and<br \/>\nat the Closing Parent and Acquisition shall have delivered to the Company a<br \/>\ncertificate to that effect;<\/p>\n<p>                  (b) each of the obligations of Parent and Acquisition to be<br \/>\nperformed at or before the Effective Time pursuant to the terms of this<br \/>\nAgreement shall have been duly performed in all material respects at or before<br \/>\nthe Effective Time, and at the Closing Parent and Acquisition shall have<br \/>\ndelivered to the Company a certificate to that effect;<\/p>\n<p>                  (c) each Parent Affiliate shall have delivered and performed<br \/>\nhis or her obligations under the letter referenced in Section 4.15;<\/p>\n<p>                  (d) the shares of Parent Common Stock issuable to the Company<br \/>\nstockholders pursuant to this Agreement and such other shares required to be<br \/>\nreserved for issuance in connection with the Merger shall have been authorized<br \/>\nfor listing on the Nasdaq Stock Market (or any subsequent national securities<br \/>\nexchange on which shares of Parent Common Stock are then listed for trading)<br \/>\nupon official notice of issuance;<\/p>\n<p>                  (e) the opinion of Sullivan &amp; Cromwell, counsel to the<br \/>\nCompany, addressed to the Company substantially to the effect that (i) the<br \/>\nMerger will be treated for federal income tax purposes as a reorganization<br \/>\nwithin the meaning of Section 368(a) of the Code; (ii) each of Parent,<br \/>\nAcquisition and the Company will be a party to the reorganization within the<br \/>\nmeaning of Section 368(b) of the Code; and (iii) no gain or loss will be<br \/>\nrecognized by a stockholder of the Company as a result of the Merger with<br \/>\nrespect to Shares converted into shares of Parent Common Stock (other than with<br \/>\nrespect to cash received in lieu of fractional shares of Parent Common Stock),<br \/>\ndated the Closing Date, shall have been delivered and such opinion shall not<br \/>\nhave been withdrawn or modified in any material respect;<\/p>\n<p>                  (f) there shall have been no events, changes or effects with<br \/>\nrespect to Parent or its subsidiaries (other than such events, changes or<br \/>\neffects that arise out of or result from the execution of this Agreement or the<br \/>\nproposed consummation of the Merger and the other transactions contemplated<br \/>\nhereby) having or which would have a Parent Material Adverse Effect;<\/p>\n<p>                  (g) Parent and Acquisition shall have executed with State<br \/>\nStreet Bank and Trust Company a supplemental indenture with respect to the<br \/>\nConvertible Notes, which supplemental indenture shall provide that upon<br \/>\nconsummation of the Merger, (i) Acquisition shall assume the due and punctual<br \/>\npayment of the principal of and interest on all the Convertible Notes and the<br \/>\nperformance and observance of every covenant to be performed or observed by the<br \/>\nCompany under the Indenture under which such Convertible Notes were issued, (ii)<br \/>\nthe holder of each Convertible Note outstanding immediately following the Merger<br \/>\nthereafter shall have the right to convert such Convertible Note into Parent<br \/>\nCommon Stock at the rate of 34.90908 shares of Parent Common Stock for each<br \/>\n$1,000 principal amount of the Convertible Notes and (iii) Parent shall assume<br \/>\nas a joint obligor Acquisition&#8217;s obligations to pay the principal of and<br \/>\npremium, if any, and interest on the Convertible Notes;<\/p>\n<p>                  (h) the Agreement, dated the date hereof, between Intermedics,<br \/>\nInc. and Acquisition (the &#8220;Intermedics Consent&#8221;) shall be in full force and<br \/>\neffect without any modification or amendment that would materially and adversely<br \/>\naffect the ability of the Surviving Corporation following the Effective Time to<br \/>\nconduct the operations of the Company as such operations are conducted by the<br \/>\nCompany on the date of this Agreement;<\/p>\n<p>                  (i) Acquisition shall have offered to enter into an employment<br \/>\nagreement in the form annexed hereto as Exhibit A with each of the persons<br \/>\nlisted in Section 5.2(i) of the Company Disclosure Schedule; and<\/p>\n<p>                  (j) Intermedics, Inc. and Acquisition shall have entered into<br \/>\nthe 1996 License Agreement referred to in the Intermedics Consent, such 1996<br \/>\nLicense Agreement to be in substance as described in the Intermedics Consent as<br \/>\ndetermined in the reasonable judgment of the Company.<\/p>\n<p>                  SECTION 5.3. Conditions to the Obligations of Parent and<br \/>\nAcquisition. The respective obligations of Parent and Acquisition to effect the<br \/>\nMerger are subject to the satisfaction at or prior to the Effective Time of the<br \/>\nfollowing conditions:<\/p>\n<p>                  (a) the representations and warranties of the Company<br \/>\ncontained in this Agreement or in any other document delivered pursuant hereto<br \/>\nshall be true and correct in all material respects at and as of the Effective<br \/>\nTime with the same effect as if made at and as of the Effective Time, and at the<br \/>\nClosing the Company shall have delivered to Parent and Acquisition a certificate<br \/>\nto that effect;<\/p>\n<p>                  (b) each of the obligations of the Company to be performed at<br \/>\nor before the Effective Time pursuant to the terms of this Agreement shall have<br \/>\nbeen duly performed in all material respects at or before the Effective Time,<br \/>\nand at the Closing the Company shall have delivered to Parent and Acquisition a<br \/>\ncertificate to that effect;<\/p>\n<p>                  (c) each Company Affiliate shall have delivered and performed<br \/>\nhis or her obligations under the letter referenced in Section 4.15;<\/p>\n<p>                  (d) there shall have been no events, changes or effects with<br \/>\nrespect to the Company or its subsidiaries (other than such events, changes or<br \/>\neffects that arise out of or result from the execution of this Agreement or the<br \/>\nproposed consummation of the Merger and the other transactions contemplated<br \/>\nhereby) having or which would have a Company Material Adverse Effect;<\/p>\n<p>                  (e) the opinion of Weil, Gotshal &amp; Manges LLP, addressed to<br \/>\nParent, substantially to the effect that (i) the Merger will be treated for<br \/>\nfederal income tax purposes as a reorganization within the meaning of Section<br \/>\n368(a) of the Code; (ii) each of Parent, Acquisition and the Company will be a<br \/>\nparty to the reorganization within the meaning of Section 368(b) of the Code;<br \/>\nand (iii) no gain or loss will be recognized by Parent, Acquisition or the<br \/>\nCompany as a result of the Merger, dated the Closing Date, shall have been<br \/>\ndelivered and such opinion shall not have been withdrawn or modified in any<br \/>\nmaterial respect; and<\/p>\n<p>                  (f) the Surviving Corporation shall have entered into an<br \/>\nemployment agreement with each of the persons listed in Section 5.3(f) of the<br \/>\nParent Disclosure Schedule.<\/p>\n<p>                                    ARTICLE 6<\/p>\n<p>                         TERMINATION; AMENDMENT; WAIVER<\/p>\n<p>                  SECTION 6.1. Termination. This Agreement may be terminated and<br \/>\nthe Merger may be abandoned at any time, but prior to the Effective Time:<\/p>\n<p>                  (a) by mutual written consent of Parent, Acquisition and the<br \/>\nCompany;<\/p>\n<p>                  (b) by Parent and Acquisition or the Company if (i) the Merger<br \/>\nhas not been consummated by May 1, 1997, PROVIDED that no party may terminate<br \/>\nthis Agreement pursuant to this clause (i) if such party&#8217;s failure to fulfill<br \/>\nany of its obligations under this Agreement shall have been the reason that the<br \/>\nEffective Time shall not have occurred on or before said date, or (ii) the<br \/>\nCompany or Parent shall have convened a meeting of its respective stockholders<br \/>\nand failed to obtain the requisite vote of its respective stockholders; or<\/p>\n<p>                  (c) by the Company if (i) there shall have been a breach of<br \/>\nany representation or warranty on the part of Parent or Acquisition set forth in<br \/>\nthis Agreement, or if any representation or warranty of Parent or Acquisition<br \/>\nshall have become untrue, in either case such that the conditions set forth in<br \/>\nSection 5.2(a) would be incapable of being satisfied by May 1, 1997 (or as<br \/>\notherwise extended), (ii) there shall have been a breach by Parent or<br \/>\nAcquisition of any of their respective covenants or agreements hereunder having<br \/>\na Parent Material Adverse Effect or materially adversely affecting the<br \/>\nconsummation of the Merger, and Parent or Acquisition, as the case may be, has<br \/>\nnot cured such breach within 20 business days after notice by the Company<br \/>\nthereof, or (iii) the Company enters into a definitive agreement relating to a<br \/>\nSuperior Proposal in accordance with Section 4.3(b) (provided that such<br \/>\ntermination shall not be effective until payment of the amount required under<br \/>\nSection 6.3(a)).<\/p>\n<p>                  (d) by Parent and Acquisition if (i) there shall have been a<br \/>\nbreach of any representation or warranty on the part of the Company set forth in<br \/>\nthis Agreement, or if any representation or warranty of the Company shall have<br \/>\nbecome untrue, in either case such that the conditions set forth in Section<br \/>\n5.3(a) would be incapable of being satisfied by May 1, 1997 (or as otherwise<br \/>\nextended), (ii) there shall have been a breach by the Company of its covenants<br \/>\nor agreements hereunder having a Company Material Adverse Effect or materially<br \/>\nadversely affecting the consummation of the Merger, and the Company has not<br \/>\ncured such breach within 20 business days after notice by Parent or Acquisition<br \/>\nthereof, or (iii) the Company Board shall have withdrawn, modified or changed<br \/>\nits approval or recommendation of this Agreement or the Merger, shall have<br \/>\nrecommended to the Company&#8217;s stockholders any Acquisition Proposal (other than<br \/>\nthe Merger), shall have failed to call, give notice of, convene or hold a<br \/>\nstockholders&#8217; meeting to vote upon the Merger, or shall have adopted any<br \/>\nresolution to effect any of the foregoing, or the Company shall have entered<br \/>\ninto a definitive agreement relating to a Superior Proposal.<\/p>\n<p>                  SECTION 6.2. Effect of Termination. In the event of the<br \/>\ntermination and abandonment of this Agreement pursuant to Section 6.1, this<br \/>\nAgreement shall forthwith become void and have no effect, without any liability<br \/>\non the part of any party hereto or its affiliates, directors, officers or<br \/>\nshareholders, other than the provisions of this Section 6.2 and Sections 4.6(c)<br \/>\nand 6.3. Nothing contained in this Section 6.2 shall relieve any party from<br \/>\nliability for any wilful breach of this Agreement.<\/p>\n<p>                  SECTION 6.3. Fees and Expenses.<\/p>\n<p>                  (a) In the event that this Agreement shall be terminated<br \/>\npursuant to:<\/p>\n<p>                  (i) Sections 6.1(d)(i) or 6.1(d)(ii) as a result of a wilful<br \/>\nbreach by the Company and, within twelve months thereafter, the Company enters<br \/>\ninto an agreement with respect to any Acquisition Proposal (other than the<br \/>\nMerger)), or<\/p>\n<p>                  (ii) Sections 6.1(c)(iii) or 6.1(d)(iii), then Parent and<br \/>\nAcquisition would suffer direct and substantial damages, which damages cannot be<br \/>\ndetermined with reasonable certainty. To compensate Parent and Acquisition for<br \/>\nsuch damages, and in full satisfaction and settlement of any claims that Parent<br \/>\notherwise might have against the Company in respect of any such termination of<br \/>\nthis Agreement, the Company shall pay to Parent the amount of Fourteen Million<br \/>\nFive Hundred Thousand Dollars ($14,500,000) (and not as a penalty) as follows:<br \/>\n(i) in the case of a termination under Section 6.1(d)(i) or 6.1(d)(ii), such<br \/>\namount shall be paid on the date the Company consummates an Acquisition Proposal<br \/>\nand (ii) in the case of a termination under Section 6.1(c)(iii) or 6.1(d)(iii),<br \/>\nsuch amount shall be paid on the date of such termination. Notwithstanding the<br \/>\nimmediately preceding sentence, any payment as a result of a termination of this<br \/>\nAgreement pursuant to Section 6.1(d)(i) or 6.1(d)(ii) shall be reduced by the<br \/>\namount of any damages actually recovered by Parent or Acquisition in respect<br \/>\nthereof.<\/p>\n<p>                  (b) If the Company Board withdraws its recommendation to<br \/>\nCompany stockholders that they vote to approve this Agreement and related<br \/>\nmatters by reason of changes to the market prices of Parent Common Stock (in the<br \/>\nabsence of any occurrences that had or would have a Parent Material Adverse<br \/>\nEffect) following the date hereof and the Merger is not consummated by reason of<br \/>\nsuch withdrawal, then the Company shall pay to Parent the amount of Fourteen<br \/>\nMillion Five Hundred Thousand Dollars ($14,500,000). Such payment shall not be<br \/>\ndeemed to be the exclusive remedy or remedies for any breach of this Agreement<br \/>\nby the Company, but shall be in addition to all other remedies available to<br \/>\nParent at law or equity. Nothing contained in this Section 6.3(b) shall be an<br \/>\nadmission by Parent that a change in the market prices of Parent Common Stock<br \/>\n(in the absence of any occurrences that had or would have a Parent Material<br \/>\nAdverse Effect) following the date hereof is an appropriate basis for the<br \/>\nCompany Board to withdraw its recommendation to Company stockholders pursuant to<br \/>\nSection 4.5 hereof.<\/p>\n<p>                  (c) Each party shall bear its own expenses in connection with<br \/>\nthis Agreement and the transactions contemplated hereby. The cost of printing<br \/>\nthe S-4 and the Proxy Statement shall be borne equally by the Company and<br \/>\nParent.<\/p>\n<p>                  SECTION 6.4. Amendment. This Agreement may be amended by<br \/>\naction taken by the Company, Parent and Acquisition at any time before or after<br \/>\napproval of this Agreement by the stockholders of the Company but, after any<br \/>\nsuch approval, no amendment shall be made which requires the approval of such<br \/>\nstockholders under applicable law without such approval. This Agreement may not<br \/>\nbe amended except by an instrument in writing signed on behalf of the parties<br \/>\nhereto.<\/p>\n<p>                  SECTION 6.5. Extension; Waiver. At any time prior to the<br \/>\nEffective Time, each party hereto (for these purposes, Parent and Acquisition<br \/>\nshall together be deemed one party and the Company shall be deemed the other<br \/>\nparty) may (i) extend the time for the performance of any of the obligations or<br \/>\nother acts of the other party, (ii) waive any inaccuracies in the<br \/>\nrepresentations and warranties of the other party contained herein or in any<br \/>\ndocument, certificate or writing delivered pursuant hereto or (iii) waive<br \/>\ncompliance by the other party with any of the agreements or conditions contained<br \/>\nherein. Any agreement on the part of either party hereto to any such extension<br \/>\nor waiver shall be valid only if set forth in an instrument in writing signed on<br \/>\nbehalf of such party. The failure of either party hereto to assert any of its<br \/>\nrights hereunder shall not constitute a waiver of such rights.<\/p>\n<p>                                    ARTICLE 7<\/p>\n<p>                                  MISCELLANEOUS<\/p>\n<p>                  SECTION 7.1. Nonsurvival of Representations and Warranties.<br \/>\nThe representations and warranties made herein shall not survive beyond the<br \/>\nEffective Time or a termination of this Agreement.<\/p>\n<p>                  SECTION 7.2.  Entire Agreement; Assignment.  This Agreement<\/p>\n<p>                  (a) constitutes the entire agreement between the parties<br \/>\nhereto with respect to the subject matter hereof and supersedes all other prior<br \/>\nagreements and understandings, both written and oral, between the parties with<br \/>\nrespect to the subject matter hereof; and<\/p>\n<p>                  (b) shall not be assigned by operation of law or otherwise;<br \/>\nPROVIDED, HOWEVER, that Acquisition may assign any or all of its rights and<br \/>\nobligations under this Agreement to any direct wholly-owned subsidiary of<br \/>\nParent, but no such assignment shall relieve Acquisition of its obligations<br \/>\nhereunder if such assignee does not perform such obligations.<\/p>\n<p>                  SECTION 7.3. Validity. If any provision of this Agreement, or<br \/>\nthe application thereof to any person or circumstance, is held invalid or<br \/>\nunenforceable, the remainder of this Agreement, and the application of such<br \/>\nprovision to other persons or circumstances, shall not be affected thereby, and<br \/>\nto such end, the provisions of this Agreement are agreed to be severable.<\/p>\n<p>                  SECTION 7.4. Notices. All notices, requests, claims, demands<br \/>\nand other communications hereunder shall be in writing and shall be given (and<br \/>\nshall be deemed to have been duly given upon receipt) by delivery in person, by<br \/>\ncable, telegram, facsimile or telex, or by registered or certified mail (postage<br \/>\nprepaid, return receipt requested), to the other party as follows:<\/p>\n<p>           if to Parent or<br \/>\n           to Acquisition to:     St. Jude Medical, Inc.<br \/>\n                                  One Lillehei Plaza<br \/>\n                                  St. Paul, MN 55117<br \/>\n                                  Attention: General Counsel<br \/>\n                                  Facsimile: (612) 490-4333<\/p>\n<p>           with a copy to:        Weil, Gotshal &amp; Manges LLP<br \/>\n                                  767 Fifth Avenue<br \/>\n                                  New York, NY 10153<br \/>\n                                  Attention: Dennis J. Block, Esq.<br \/>\n                                  Facsimile: (212) 310-8007<\/p>\n<p>           if to the Company to:  Ventritex, Inc.<br \/>\n                                  701 East Evelyn Avenue<br \/>\n                                  Sunnyvale, CA 94086<br \/>\n                                  Attention:  Mr. Frank M. Fischer<br \/>\n                                  Facsimile: (408) 738-0285<\/p>\n<p>           with a copy to:        Sullivan &amp; Cromwell<br \/>\n                                  125 Broad Street<br \/>\n                                  New York, NY 10004<br \/>\n                                  Attention:  Benjamin F. Stapleton, Esq.<br \/>\n                                  Facsimile: (212) 558-3588<\/p>\n<p>or to such other address as the person to whom notice is given may have<br \/>\npreviously furnished to the other in writing in the manner set forth above.<\/p>\n<p>                  SECTION 7.5. Governing Law. This Agreement shall be governed<br \/>\nby and construed in accordance with the laws of the State of Delaware, without<br \/>\nregard to the principles of conflicts of law thereof.<\/p>\n<p>                  SECTION 7.6. Descriptive Headings. The descriptive headings<br \/>\nherein are inserted for convenience of reference only and are not intended to be<br \/>\npart of or to affect the meaning or interpretation of this Agreement.<\/p>\n<p>                  SECTION 7.7. Parties in Interest. This Agreement shall be<br \/>\nbinding upon and inure solely to the benefit of each party hereto and its<br \/>\nsuccessors and permitted assigns, and except as provided in Sections 4.10 and<br \/>\n7.2 nothing in this Agreement, express or implied, is intended to or shall<br \/>\nconfer upon any other person any rights, benefits or remedies of any nature<br \/>\nwhatsoever under or by reason of this Agreement.<\/p>\n<p>                  SECTION 7.8. Severability. If any term or other provision of<br \/>\nthis Agreement is invalid, illegal or unenforceable, all other provisions of<br \/>\nthis Agreement shall remain in full force and effect so long as the economic or<br \/>\nlegal substance of the transactions contemplated hereby is not affected in any<br \/>\nmanner materially adverse to any party.<\/p>\n<p>                  SECTION 7.9. Specific Performance. The parties hereto<br \/>\nacknowledge that irreparable damage would result if this Agreement were not<br \/>\nspecifically enforced, and they therefore consent that the rights and<br \/>\nobligations of the parties under this Agreement may be enforced by a decree of<br \/>\nspecific performance issued by a court of competent jurisdiction. Such remedy<br \/>\nshall, however, not be exclusive and, shall be in addition to any other remedies<br \/>\nwhich any party may have under this Agreement or otherwise.<\/p>\n<p>                  SECTION 7.10. Subsidiaries. The term &#8220;subsidiary&#8221; shall mean,<br \/>\nwhen used with reference to any entity, any entity more than fifty percent (50%)<br \/>\nof the outstanding voting securities or interests (including membership<br \/>\ninterests) of which are owned directly or indirectly by such former entity.<\/p>\n<p>                  SECTION 7.11. Counterparts. This Agreement may be executed in<br \/>\none or more counterparts, each of which shall be deemed to be an original, but<br \/>\nall of which shall constitute one and the same agreement.<\/p>\n<p>           IN WITNESS WHEREOF, each of the parties has caused this Agreement to<br \/>\nbe duly executed on its behalf as of the day and year first above written.<\/p>\n<p>                                       ST. JUDE MEDICAL, INC.<\/p>\n<p>                                       By: \/s\/ Ronald A. Matricaria<br \/>\n                                           &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\n                                       Name: Ronald A. Matricaria<br \/>\n                                       Title: President and Chief Executive<br \/>\n                                              Officer<\/p>\n<p>                                       PACESETTER, INC.<\/p>\n<p>                                       By: \/s\/ Patrick Forteau<br \/>\n                                           &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\n                                       Name: Patrick Forteau<br \/>\n                                       Title: President<\/p>\n<p>                                       VENTRITEX, INC.<\/p>\n<p>                                       By: \/s\/ Frank M. Fischer<br \/>\n                                           &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\n                                       Name: Frank M. Fischer<br \/>\n                                       Title: President and Chief Executive<br \/>\n                                              Officer<\/p>\n","protected":false},"template":"","meta":{"_acf_changed":false,"_stopmodifiedupdate":true,"_modified_date":"","_cloudinary_featured_overwrite":false},"corporate_contracts_companies":[8909],"corporate_contracts_industries":[9436],"corporate_contracts_types":[9622,9626],"class_list":["post-43143","corporate_contracts","type-corporate_contracts","status-publish","hentry","corporate_contracts_companies-st-jude-medical-inc","corporate_contracts_industries-health__instruments","corporate_contracts_types-planning","corporate_contracts_types-planning__merger"],"acf":[],"_links":{"self":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts\/43143","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts"}],"about":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/types\/corporate_contracts"}],"wp:attachment":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/media?parent=43143"}],"wp:term":[{"taxonomy":"corporate_contracts_companies","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_companies?post=43143"},{"taxonomy":"corporate_contracts_industries","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_industries?post=43143"},{"taxonomy":"corporate_contracts_types","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_types?post=43143"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}